molecule_chembl_id,target_chembl_id,target_pref_name,standard_type,standard_relation,standard_value,standard_units,assay_chembl_id,assay_type,assay_description,document_chembl_id,readout,smiles
CHEMBL81485,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,436.52,nM,CHEMBL640498,B,Binding affinity for human cloned Alpha-2A adrenergic receptor,CHEMBL1135380,IC50,CNCC1CC2c3ccccc3Cc3ccccc3N2O1
CHEMBL83658,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,371.54,nM,CHEMBL640498,B,Binding affinity for human cloned Alpha-2A adrenergic receptor,CHEMBL1135380,IC50,CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1
CHEMBL6437,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,20.89,nM,CHEMBL640498,B,Binding affinity for human cloned Alpha-2A adrenergic receptor,CHEMBL1135380,IC50,CN1CCN2c3ccccc3Cc3ccccc3C2C1
CHEMBL83658,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,371.54,nM,CHEMBL640500,B,Binding affinity against Alpha-2A adrenergic receptor,CHEMBL1135009,IC50,CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1
CHEMBL315772,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,478.63,nM,CHEMBL640500,B,Binding affinity against Alpha-2A adrenergic receptor,CHEMBL1135009,IC50,CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1
CHEMBL133455,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,19000.0,nM,CHEMBL643238,B,Inhibitory concentration required against Alpha-2A adrenergic receptor using [3H]clonidine radioligand,CHEMBL1145094,IC50,C[C@H](N)Cc1c[nH]c2ccc3c(c12)CCCO3
CHEMBL138809,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,6200.0,nM,CHEMBL822169,B,Inhibition of idazoxane binding to noradrenaline alpha-2 receptor,CHEMBL1135809,IC50,COC1OC2(CCN(Cc3ccccc3)CC2)c2ccccc21
CHEMBL138458,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,3100.0,nM,CHEMBL822169,B,Inhibition of idazoxane binding to noradrenaline alpha-2 receptor,CHEMBL1135809,IC50,COC1Cc2ccccc2C2(CCN(CCCc3ccccc3)CC2)O1
CHEMBL141209,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,3000.0,nM,CHEMBL822169,B,Inhibition of idazoxane binding to noradrenaline alpha-2 receptor,CHEMBL1135809,IC50,COC1Cc2ccccc2C2(CCN(Cc3ccccc3)CC2)O1
CHEMBL162436,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,2.188,nM,CHEMBL640335,B,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,CHEMBL1132860,IC50,O=c1c(CCN2CCc3oc4ccccc4c3C2)c(Cc2ccccc2)nc2ccccn12
CHEMBL164612,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,0.8913,nM,CHEMBL640335,B,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,CHEMBL1132860,IC50,Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3c(Cl)cccc3c2C1
CHEMBL162490,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,0.2951,nM,CHEMBL640335,B,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,CHEMBL1132860,IC50,COc1cccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc12
CHEMBL351483,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,0.2138,nM,CHEMBL640335,B,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,CHEMBL1132860,IC50,Cc1nc2ccc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1
CHEMBL165677,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,3.89,nM,CHEMBL640335,B,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,CHEMBL1132860,IC50,Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccc(Cl)cc3c2C1
CHEMBL165350,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,0.3548,nM,CHEMBL640335,B,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,CHEMBL1132860,IC50,Cc1nc2ccc(Br)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1
CHEMBL165796,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,0.4467,nM,CHEMBL640335,B,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,CHEMBL1132860,IC50,Cc1ccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1
CHEMBL162058,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,3.548,nM,CHEMBL640335,B,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,CHEMBL1132860,IC50,COc1cc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2cc1OC
CHEMBL162501,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,0.5495,nM,CHEMBL640335,B,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,CHEMBL1132860,IC50,Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1
CHEMBL165776,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,10.23,nM,CHEMBL640335,B,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,CHEMBL1132860,IC50,Cc1nc2ccccn2c(=O)c1CCCN1CCc2oc3ccccc3c2C1
CHEMBL162826,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,0.6918,nM,CHEMBL640335,B,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,CHEMBL1132860,IC50,Cc1nc2c(O)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1
CHEMBL10316,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,8.318,nM,CHEMBL640335,B,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,CHEMBL1132860,IC50,c1ccc2c(c1)OCC(C1=NCCN1)O2
CHEMBL163247,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,0.5888,nM,CHEMBL640335,B,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,CHEMBL1132860,IC50,Cc1nc2c(Cl)cc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1
CHEMBL162232,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,0.3388,nM,CHEMBL640335,B,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,CHEMBL1132860,IC50,Cc1cc(C)n2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1
CHEMBL351200,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,0.6026,nM,CHEMBL640335,B,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,CHEMBL1132860,IC50,Cc1nc2c(C)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1
CHEMBL162147,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1.175,nM,CHEMBL640335,B,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,CHEMBL1132860,IC50,Cc1nc2c(Cl)cc(C(F)(F)F)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1
CHEMBL162682,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,0.2399,nM,CHEMBL640335,B,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,CHEMBL1132860,IC50,Cc1nc2ccc(I)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1
CHEMBL165181,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1.738,nM,CHEMBL640335,B,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,CHEMBL1132860,IC50,Cc1nc2ccccn2c(=O)c1CCN1CCc2sc3ccccc3c2C1
CHEMBL654,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,85.11,nM,CHEMBL640335,B,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,CHEMBL1132860,IC50,CN1CCN2c3ncccc3Cc3ccccc3C2C1
CHEMBL162370,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,0.3467,nM,CHEMBL640335,B,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,CHEMBL1132860,IC50,Cc1ccc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2c1
CHEMBL163190,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,0.2884,nM,CHEMBL640335,B,Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,CHEMBL1132860,IC50,Cc1nc2cccc(C)n2c(=O)c1CCN1CCc2oc3ccccc3c2C1
CHEMBL84931,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,501.19,nM,CHEMBL640499,B,Binding affinity for human cloned Alpha-2A adrenergic receptor,CHEMBL1135381,IC50,CN(C)CC1CC2c3ccccc3Cc3ccc(F)cc3N2O1
CHEMBL315772,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,478.63,nM,CHEMBL640499,B,Binding affinity for human cloned Alpha-2A adrenergic receptor,CHEMBL1135381,IC50,CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1
CHEMBL83658,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,371.54,nM,CHEMBL640499,B,Binding affinity for human cloned Alpha-2A adrenergic receptor,CHEMBL1135381,IC50,CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1
CHEMBL346389,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1100.0,nM,CHEMBL647294,B,Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor,CHEMBL1132537,IC50,O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1
CHEMBL180003,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,57.0,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,CN(C)c1nc(N[C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12
CHEMBL360081,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,71.0,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,COc1cc(OC)cc(C(=O)N[C@H]2CC[C@@H](Nc3nc(N(C)C)c4ccccc4n3)CC2)c1
CHEMBL181184,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,390.0,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,CN(C)c1nc(NC2CCC(NC(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12
CHEMBL359510,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,63.0,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(Br)c3)CC2)nc2ccccc12
CHEMBL367355,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,9.9,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,CN(C)c1nc(NCC2CCC(CNC(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12
CHEMBL360117,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,31.0,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,CN(C)c1nc(NCC2CCC(CNCc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12
CHEMBL178084,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,170.0,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,CN(C)c1nc(NC2CCC(NCc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12
CHEMBL180962,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,110.0,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,Cc1cccc(C(=O)N[C@H]2CC[C@@H](Nc3nc(N(C)C)c4ccccc4n3)CC2)c1
CHEMBL181632,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,60.0,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(C(F)(F)F)c3)CC2)nc2ccccc12
CHEMBL182235,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,44.0,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,CN(Cc1ccc(Br)cc1OC(F)(F)F)CC1CCC(CNc2nc(N(C)C)c3ccccc3n2)CC1
CHEMBL360876,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,520.0,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,CN(C)c1nc(NC2CCN(Cc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12
CHEMBL362193,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,130.0,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(F)c3)CC2)nc2ccccc12
CHEMBL181099,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,150.0,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(C#N)c3)CC2)nc2ccccc12
CHEMBL181393,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,570.0,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,CN(C)c1nc(NC2CCC(CNC(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12
CHEMBL537846,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,7.7,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,CN(C)c1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12.Cl
CHEMBL181466,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,360.0,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,CN(C)c1nc(NC2CCC(CNCc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12
CHEMBL181217,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,130.0,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,CN(C)c1nc(N[C@H]2CC[C@@H](CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12
CHEMBL361442,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,150.0,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)cc3)CC2)nc2ccccc12
CHEMBL179878,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,76.0,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(Cl)c3)CC2)nc2ccccc12
CHEMBL181383,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,97.0,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc([N+](=O)[O-])c3)CC2)nc2ccccc12
CHEMBL360671,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,170.0,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,CN(C)c1nc(NC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12
CHEMBL182150,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,260.0,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)c(F)c3)CC2)nc2ccccc12
CHEMBL362400,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,47.0,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)c(Cl)c3)CC2)nc2ccccc12
CHEMBL360159,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,200.0,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)c(F)c3F)CC2)nc2ccccc12
CHEMBL181727,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,34.0,nM,CHEMBL831139,B,Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells,CHEMBL1142793,IC50,CN(C)c1nc(NCC2CCC(CN(C)S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12
CHEMBL193438,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,7.7,nM,CHEMBL831429,B,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,CHEMBL1145250,IC50,CN(C)c1nc(NCC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12
CHEMBL17645,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,97.0,nM,CHEMBL831429,B,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,CHEMBL1145250,IC50,Nc1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12
CHEMBL192266,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,100.0,nM,CHEMBL831429,B,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,CHEMBL1145250,IC50,Nc1nc(NCC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12
CHEMBL425012,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,140.0,nM,CHEMBL831429,B,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,CHEMBL1145250,IC50,O=S(=O)(NCC1CCC(CNc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F
CHEMBL195123,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,86.0,nM,CHEMBL831429,B,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,CHEMBL1145250,IC50,CN(C)c1nc(NCC2CCC(CNS(C)(=O)=O)CC2)nc2ccccc12
CHEMBL193666,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,58.0,nM,CHEMBL831429,B,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,CHEMBL1145250,IC50,CCCCS(=O)(=O)NCC1CCC(CNc2nc(N(C)C)c3ccccc3n2)CC1
CHEMBL193970,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,21.0,nM,CHEMBL831429,B,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,CHEMBL1145250,IC50,CN(C)c1nc(NCC2CCC(NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12
CHEMBL194602,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,110.0,nM,CHEMBL831429,B,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,CHEMBL1145250,IC50,CN(C)c1nc(NC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12
CHEMBL193771,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,47.0,nM,CHEMBL831429,B,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,CHEMBL1145250,IC50,CN(C)c1nc(NC2CCC(NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12
CHEMBL195810,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,130.0,nM,CHEMBL831429,B,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,CHEMBL1145250,IC50,O=S(=O)(NCC1CCC(Nc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F
CHEMBL195346,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,57.0,nM,CHEMBL831429,B,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,CHEMBL1145250,IC50,O=S(=O)(NC1CCC(Nc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F
CHEMBL194173,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,5.6,nM,CHEMBL831429,B,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,CHEMBL1145250,IC50,CN(C)c1nc(NCC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12
CHEMBL360671,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,170.0,nM,CHEMBL831429,B,Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912,CHEMBL1145250,IC50,CN(C)c1nc(NC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12
CHEMBL493091,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,185.0,nM,CHEMBL985484,B,Displacement of [3H]MK912 from human cloned adrenergic alpha-2a receptor,CHEMBL1140141,IC50,CN(C)CCCOc1ccc(CCNC(=O)c2cc(Br)c[nH]2)cc1Br
CHEMBL461571,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1650.0,nM,CHEMBL980764,B,Displacement of radioligand from adrenergic alpha2A receptor,CHEMBL1139415,IC50,Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1
CHEMBL257991,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,2830.0,nM,CHEMBL1007882,B,Inhibition of adrenergic alpha2A receptor,CHEMBL1140923,IC50,O=C(Nc1ccccc1-c1cn2c(CN3CCNCC3)csc2n1)c1cnc2ccccc2n1
CHEMBL470432,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,891.25,nM,CHEMBL964030,B,Displacement of [3H]RX821002 form human recombinant alpha2A adrenergic receptor,CHEMBL1153939,IC50,CCCN1CCC(COc2nc3scc(C)c3n3cccc23)CC1
CHEMBL475969,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1097.0,nM,CHEMBL989588,B,Inhibition of human adrenergic alpha2A receptor,CHEMBL1143393,IC50,CC1=C(CCN(C)C)c2cc(S(=O)(=O)Nc3cccc4ccccc34)ccc2C1
CHEMBL477650,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,700.0,nM,CHEMBL989588,B,Inhibition of human adrenergic alpha2A receptor,CHEMBL1143393,IC50,CC1=C(CCN(C)C)c2cc(NS(=O)(=O)c3csc4ccccc34)ccc2C1
CHEMBL584606,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,320.0,nM,CHEMBL1046745,B,Displacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 mins,CHEMBL1154181,IC50,C=Cc1c(C)nn(CCCN2CCN(c3ccc(C)cc3)CC2)c(=O)c1N
CHEMBL537669,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,3.67,nM,CHEMBL1046745,B,Displacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 mins,CHEMBL1154181,IC50,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O.Cl
CHEMBL584554,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1930.0,nM,CHEMBL1048463,B,Inhibition of adrenergic alpha2A receptor,CHEMBL1154177,IC50,CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C(=O)Nc2ccccc2)C1
CHEMBL182150,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,104.0,nM,CHEMBL1037060,B,Displacement of [3H]MK-912 from human adrenergic alpha2A receptor,CHEMBL1156067,IC50,CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)c(F)c3)CC2)nc2ccccc12
CHEMBL567791,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,730.0,nM,CHEMBL1037060,B,Displacement of [3H]MK-912 from human adrenergic alpha2A receptor,CHEMBL1156067,IC50,Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)cc3)CC2)n1
CHEMBL568400,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,130.0,nM,CHEMBL1037060,B,Displacement of [3H]MK-912 from human adrenergic alpha2A receptor,CHEMBL1156067,IC50,Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)c(Cl)c3)CC2)n1
CHEMBL583014,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,200.0,nM,CHEMBL1037060,B,Displacement of [3H]MK-912 from human adrenergic alpha2A receptor,CHEMBL1156067,IC50,Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)n1
CHEMBL567993,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,580.0,nM,CHEMBL1037060,B,Displacement of [3H]MK-912 from human adrenergic alpha2A receptor,CHEMBL1156067,IC50,Cc1cccc(C(=O)N[C@H]2CC[C@@H](Nc3ncc(C)c(N(C)C)n3)CC2)c1
CHEMBL578170,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1770.0,nM,CHEMBL1037060,B,Displacement of [3H]MK-912 from human adrenergic alpha2A receptor,CHEMBL1156067,IC50,Cc1ccc(C(=O)N[C@H]2CC[C@@H](Nc3ncc(C)c(N(C)C)n3)CC2)cc1
CHEMBL565551,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,470.0,nM,CHEMBL1037060,B,Displacement of [3H]MK-912 from human adrenergic alpha2A receptor,CHEMBL1156067,IC50,Cc1cnc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)cc3)CC2)nc1N(C)C
CHEMBL577912,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1590.0,nM,CHEMBL1037060,B,Displacement of [3H]MK-912 from human adrenergic alpha2A receptor,CHEMBL1156067,IC50,Cc1cnc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)cc3)CC2)nc1N(C)C
CHEMBL577904,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,210.0,nM,CHEMBL1037060,B,Displacement of [3H]MK-912 from human adrenergic alpha2A receptor,CHEMBL1156067,IC50,Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3ccc(F)c(F)c3)CC2)nc1N(C)C
CHEMBL566075,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,310.0,nM,CHEMBL1037060,B,Displacement of [3H]MK-912 from human adrenergic alpha2A receptor,CHEMBL1156067,IC50,Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)nc1N(C)C
CHEMBL605938,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,891.0,nM,CHEMBL1071169,B,Inhibition of human alpha-2a adrenergic receptor,CHEMBL1152611,IC50,O=S(=O)(Nc1ccc2c(c1)C(C1CCNC1)=CC2)c1c(Cl)nc2sccn12
CHEMBL593889,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1213.0,nM,CHEMBL1071169,B,Inhibition of human alpha-2a adrenergic receptor,CHEMBL1152611,IC50,CC1=C(C2CCCN(C)C2)c2cc(NS(=O)(=O)c3c(Cl)nc4sccn34)ccc2C1
CHEMBL1083787,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,35000.0,nM,CHEMBL1118797,B,Binding affinity to adrenergic alpha2A receptor,CHEMBL1155527,IC50,O=C(NCCCCN1CCCCC1)Nc1ccc(-c2ccc(F)cc2)nc1
CHEMBL221753,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,3102.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1.[Cl-]
CHEMBL493,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,15.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
CHEMBL990,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,3644.3,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12
CHEMBL1366,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,884.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,
CHEMBL508112,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,899.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,c1ccc2sc(SSc3nc4ccccc4s3)nc2c1
CHEMBL290106,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,3824.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O
CHEMBL1201203,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,544.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN1[C@@H]2CC[C@H]1C[C@@H](OC(c1ccccc1)c1ccccc1)C2
CHEMBL1476898,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,4556.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,
CHEMBL296419,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,4846.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1
CHEMBL844,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,298.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,Brc1c(NC2=NCCN2)ccc2nccnc12
CHEMBL1458880,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,6918.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,
CHEMBL1113,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1314.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2
CHEMBL1381098,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,6272.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,S=C=Nc1cccc2ccccc12
CHEMBL153062,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,6780.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CCCCCCCCCc1ccc(O)cc1
CHEMBL195437,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,14288.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CCCCCCCCc1ccc(O)cc1
CHEMBL633,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,312.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1
CHEMBL1403281,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,7.946,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
CHEMBL1365675,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,926.9,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1
CHEMBL629,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,351.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN(C)CCC=C1c2ccccc2CCc2ccccc21
CHEMBL311469,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,21061.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2
CHEMBL1491,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,602.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl
CHEMBL1289,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1222.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,Clc1cc(Cl)c(OCC#CI)cc1Cl
CHEMBL305660,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,831.6,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1
CHEMBL64894,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,536.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]
CHEMBL808,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,4325.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1
CHEMBL679,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,737.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CNC[C@H](O)c1ccc(O)c(O)c1
CHEMBL420,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,41.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,N=C(N)N/N=C/c1c(Cl)cccc1Cl
CHEMBL496,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,5496.5,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl
CHEMBL50588,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,38.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21
CHEMBL862,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,134.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl
CHEMBL1385840,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,6.296,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
CHEMBL30008,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,581.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1
CHEMBL119443,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1680.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL726,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,215.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1
CHEMBL442,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,2.123,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL1108,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,2965.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
CHEMBL54,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,4973.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL134,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,280.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,Clc1cccc(Cl)c1NC1=NCCN1
CHEMBL7002,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,16551.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1
CHEMBL1729,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1777.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC
CHEMBL1628227,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1335.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN(C)CCC=C1c2ccccc2COc2ccccc21
CHEMBL648,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1551.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN1CCN(C(c2ccccc2)c2ccccc2)CC1
CHEMBL1255837,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1.993,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O
CHEMBL1732,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1.032,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL964,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,4904.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CCN(CC)C(=S)SSC(=S)N(CC)CC
CHEMBL104,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,11886.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1
CHEMBL411,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,14127.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1
CHEMBL954,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,936.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1
CHEMBL42,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,90.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL1200406,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,4313.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O
CHEMBL71,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,352.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21
CHEMBL43064,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,444.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1
CHEMBL219916,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,2740.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1
CHEMBL415,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1414.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21
CHEMBL516,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,283.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1
CHEMBL1479,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,18328.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C
CHEMBL1201353,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,20333.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1
CHEMBL723,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,106.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12
CHEMBL334255,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,242.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-]
CHEMBL1626,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,183.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1
CHEMBL762,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,23.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1
CHEMBL55,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1375.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1
CHEMBL564,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,337.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN(C)CCCN1c2ccccc2Sc2ccccc21
CHEMBL643,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,681.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CC(CN1c2ccccc2Sc2ccccc21)N(C)C
CHEMBL531,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,264.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL2,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,2638.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
CHEMBL511,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,2976.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,COc1ccc(CN(CCN(C)C)c2ccccn2)cc1
CHEMBL715,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,541.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL597,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,6.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1
CHEMBL1909072,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,66.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1
CHEMBL1262,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,4082.7,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1
CHEMBL445,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,732.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CNCCC=C1c2ccccc2CCc2ccccc21
CHEMBL716,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,2491.4,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
CHEMBL728,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,169.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1
CHEMBL7568,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,2280.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12
CHEMBL900,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,2156.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,Cc1ccccc1C(OCCN(C)C)c1ccccc1
CHEMBL21731,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1824.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CNCCCC12CCC(c3ccccc31)c1ccccc12
CHEMBL86,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,2721.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC
CHEMBL6437,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,43.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN1CCN2c3ccccc3Cc3ccccc3C2C1
CHEMBL91,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,3966.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1
CHEMBL1200633,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,5839.8,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O
CHEMBL1221512,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,432.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS
CHEMBL19215,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,58.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21
CHEMBL1909062,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,3597.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,
CHEMBL157138,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,0.31,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL787,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,3919.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1
CHEMBL1909065,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,180.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C
CHEMBL1411979,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1165.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN(C)CCN(Cc1cccs1)c1ccccn1
CHEMBL60889,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,3679.4,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1
CHEMBL1201356,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1590.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL157101,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,19783.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1
CHEMBL395110,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1456.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1
CHEMBL1670,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,7347.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1
CHEMBL1065,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1631.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1
CHEMBL534,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,2187.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1
CHEMBL119385,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,34167.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl
CHEMBL621,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,909.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12
CHEMBL6966,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,579.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC
CHEMBL15245,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,6.151,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
CHEMBL611,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,13832.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC
CHEMBL479,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,133.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2
CHEMBL972,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1798.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,C#CCN(C)[C@H](C)Cc1ccccc1
CHEMBL1221,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,4043.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1
CHEMBL83,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1935.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1
CHEMBL84158,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,2078.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC
CHEMBL822,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,5702.9,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12
CHEMBL85,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,9.674,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL12948,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,4809.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CC1CCC(NC(=O)N(CCCl)N=O)CC1
CHEMBL809,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,288.8,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21
CHEMBL404849,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,2023.2,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1
CHEMBL833,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,382.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,Clc1ccccc1CN1CCc2sccc2C1
CHEMBL1306,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,983.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1
CHEMBL26,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,2019.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC
CHEMBL508338,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,532.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,
CHEMBL81,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1664.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,IC50,O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12
CHEMBL2203713,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,24000.0,nM,CHEMBL2209827,B,Inhibition of alpha2A adrenergic receptor,CHEMBL2203205,IC50,N=C(Nc1ccc2c(c1)CCN2C1CCNCC1)c1cccs1
CHEMBL513389,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,0.5,nM,CHEMBL2395774,B,Binding affinity to human adrenergic alpha2 receptor by radioligand displacement assay,CHEMBL2390917,IC50,Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2
CHEMBL15245,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,8.4,nM,CHEMBL2395285,B,Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins,CHEMBL2390918,IC50,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
CHEMBL3403995,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1000.0,nM,CHEMBL3406661,B,Inhibition of alpha-adrenoceptor 2A (unknown origin),CHEMBL3400053,IC50,COCCCOc1cc(C(=O)N(C[C@@H]2CNC[C@H]2OC(=O)NCc2ccccc2)C(C)C)ccc1OC
CHEMBL4061793,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,8000.0,nM,CHEMBL4017843,B,Antagonist activity at alpha2A-adrenergic receptor (unknown origin),CHEMBL4017458,IC50,O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC23CCCN2CCC3)cc1F
CHEMBL3091687,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,3700.0,nM,CHEMBL4149806,B,Inhibition of adrenergic alpha2A receptor (unknown origin),CHEMBL4145594,IC50,NCCCCN(C[C@H]1Cc2ccccc2CN1)[C@H]1CCCc2cccnc21
CHEMBL4174290,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,5900.0,nM,CHEMBL4149806,B,Inhibition of adrenergic alpha2A receptor (unknown origin),CHEMBL4145594,IC50,c1ccc2c(c1)CN[C@@H](CN(CC[C@H]1CCCNC1)[C@H]1CCCc3cccnc31)C2
CHEMBL1800685,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,4070.0,nM,CHEMBL4880897,B,Adrenergic alpha2A Eurofins-Panlabs radioligand binding assay,CHEMBL4507292,IC50,O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1
CHEMBL3091687,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,3700.0,nM,CHEMBL5048801,B,Inhibition of alpha 2A adrenergic receptor (unknown origin),CHEMBL5046278,IC50,NCCCCN(C[C@H]1Cc2ccccc2CN1)[C@H]1CCCc2cccnc21
CHEMBL5070958,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,11000.0,nM,CHEMBL5048801,B,Inhibition of alpha 2A adrenergic receptor (unknown origin),CHEMBL5046278,IC50,NCCCCN(C[C@H]1Cc2ncccc2CN1)[C@H]1CCCc2cccnc21
CHEMBL5076569,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,1300.0,nM,CHEMBL5048801,B,Inhibition of alpha 2A adrenergic receptor (unknown origin),CHEMBL5046278,IC50,NCCCCN(C[C@H]1Cc2cccnc2CN1)[C@H]1CCCc2cccnc21
CHEMBL5093818,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,810.0,nM,CHEMBL5048801,B,Inhibition of alpha 2A adrenergic receptor (unknown origin),CHEMBL5046278,IC50,CN(CCCCN(C[C@H]1Cc2ncccc2CN1)[C@H]1CCCc2cccnc21)C1CCC(F)(F)CC1
CHEMBL5077132,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,28000.0,nM,CHEMBL5048801,B,Inhibition of alpha 2A adrenergic receptor (unknown origin),CHEMBL5046278,IC50,CN(CCCCN(C[C@H]1Cc2ncccc2CN1)[C@H]1CCCc2cccnc21)C1CCOCC1
CHEMBL5083458,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,24000.0,nM,CHEMBL5048801,B,Inhibition of alpha 2A adrenergic receptor (unknown origin),CHEMBL5046278,IC50,c1cnc2c(c1)CN[C@@H](CN(CCCCNC1COC1)[C@H]1CCCc3cccnc31)C2
CHEMBL5082142,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,620.0,nM,CHEMBL5048801,B,Inhibition of alpha 2A adrenergic receptor (unknown origin),CHEMBL5046278,IC50,c1cnc2c(c1)CN[C@@H](CN(CCCCN1CCOCC1)[C@H]1CCCc3cccnc31)C2
CHEMBL5398630,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,3030.0,nM,CHEMBL5372883,B,Displacement of [3H]-rauwolscine from human recombinant adrenergic alpha-2A receptor expressed in CHO-K1 cells incubated for 60 mins by spectrophotometric analysis,CHEMBL5370593,IC50,O=C(O)/C=C/C(=O)O.[2H]C([2H])(Cc1c[nH]c2ccccc12)N(C)C
CHEMBL3183055,CHEMBL1867,Alpha-2a adrenergic receptor,IC50,=,2220.0,nM,CHEMBL5372883,B,Displacement of [3H]-rauwolscine from human recombinant adrenergic alpha-2A receptor expressed in CHO-K1 cells incubated for 60 mins by spectrophotometric analysis,CHEMBL5370593,IC50,CN(C)CCc1c[nH]c2ccccc12.O=C(O)/C=C/C(=O)O
CHEMBL836,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,13.4,nM,CHEMBL647964,B,Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand,CHEMBL1130166,KI,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1
CHEMBL134,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3.8,nM,CHEMBL647722,B,Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells,CHEMBL1129794,KI,Clc1cccc(Cl)c1NC1=NCCN1
CHEMBL298936,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.2,nM,CHEMBL647722,B,Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells,CHEMBL1129794,KI,Cc1c(NC2=NCCN2)ccc2c1NCCO2
CHEMBL49137,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2.0,nM,CHEMBL647722,B,Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells,CHEMBL1129794,KI,Cc1c(NC2=NCCN2)ccc2nccnc12
CHEMBL49284,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,9.6,nM,CHEMBL647722,B,Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells,CHEMBL1129794,KI,Cc1c(NC2=NCCN2)ccc2c1NCCN2
CHEMBL40650,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,94.9,nM,CHEMBL647964,B,Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand,CHEMBL1130166,KI,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21
CHEMBL611,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1500.0,nM,CHEMBL647964,B,Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand,CHEMBL1130166,KI,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC
CHEMBL647,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2.9,nM,CHEMBL647722,B,Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells,CHEMBL1129794,KI,Nc1cc(Cl)c(N=C2NCCN2)c(Cl)c1
CHEMBL92221,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,19.0,nM,CHEMBL644359,B,Binding affinity towards Alpha-2 adrenergic receptor,CHEMBL1145819,KI,Cc1c(NC2=NCCN2)cccc1-c1ccccc1
CHEMBL27251,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,92.8,nM,CHEMBL644359,B,Binding affinity towards Alpha-2 adrenergic receptor,CHEMBL1145819,KI,CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@@H]3N
CHEMBL30739,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,68.0,nM,CHEMBL647726,B,Binding affinity towards Alpha-2A adrenergic receptor,CHEMBL1133123,KI,Cc1sc(C)c2c1CCCC2c1c[nH]cn1
CHEMBL30534,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,277.0,nM,CHEMBL647726,B,Binding affinity towards Alpha-2A adrenergic receptor,CHEMBL1133123,KI,c1cc(-c2c[nH]cn2)c2ccsc2c1
CHEMBL30955,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,224.0,nM,CHEMBL647726,B,Binding affinity towards Alpha-2A adrenergic receptor,CHEMBL1133123,KI,C1=C(c2c[nH]cn2)c2sccc2CC1
CHEMBL286246,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,254.0,nM,CHEMBL647726,B,Binding affinity towards Alpha-2A adrenergic receptor,CHEMBL1133123,KI,C1=C(c2c[nH]cn2)c2ccsc2CC1
CHEMBL134,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,853.0,nM,CHEMBL647726,B,Binding affinity towards Alpha-2A adrenergic receptor,CHEMBL1133123,KI,Clc1cccc(Cl)c1NC1=NCCN1
CHEMBL284795,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,25.0,nM,CHEMBL647726,B,Binding affinity towards Alpha-2A adrenergic receptor,CHEMBL1133123,KI,Cc1sc(C)c2c1CCC=C2c1c[nH]cn1
CHEMBL284213,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,27.0,nM,CHEMBL647726,B,Binding affinity towards Alpha-2A adrenergic receptor,CHEMBL1133123,KI,c1nc(C2CCCc3sccc32)c[nH]1
CHEMBL407509,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,100.0,nM,CHEMBL649810,B,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,CHEMBL1134363,KI,C1=NCC(CC2=Cc3ccccc3CC2)N1
CHEMBL353972,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3.162,nM,CHEMBL649810,B,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,CHEMBL1134363,KI,CCC1(c2c[nH]cn2)Cc2ccccc2C1
CHEMBL167644,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,19.95,nM,CHEMBL649810,B,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,CHEMBL1134363,KI,C1=NCC(Cc2cc3ccccc3o2)N1
CHEMBL168168,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,25.12,nM,CHEMBL649810,B,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,CHEMBL1134363,KI,Clc1cccc2ccc(CC3CN=CN3)cc12
CHEMBL354611,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3.162,nM,CHEMBL649810,B,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,CHEMBL1134363,KI,C1=NC[C@@H](C2C[C@@]23CCc2ccccc2C3)N1
CHEMBL353843,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3.981,nM,CHEMBL649810,B,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,CHEMBL1134363,KI,C1=NCC(CC2Cc3ccccc3C2)N1
CHEMBL41,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,6.31,nM,CHEMBL649810,B,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,CHEMBL1134363,KI,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
CHEMBL165529,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.259,nM,CHEMBL649810,B,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,CHEMBL1134363,KI,C1=NC[C@]2(CC[C@@H]3Cc4ccccc4C[C@H]3C2)N1
CHEMBL353139,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,39.81,nM,CHEMBL649810,B,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,CHEMBL1134363,KI,Fc1cccc2c1C=C(CC1CN=CN1)CC2
CHEMBL262777,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,50.12,nM,CHEMBL649810,B,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,CHEMBL1134363,KI,CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O
CHEMBL353200,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,31.62,nM,CHEMBL649810,B,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,CHEMBL1134363,KI,Clc1cccc2c1C=C(CC1CN=CN1)CC2
CHEMBL436234,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,158.49,nM,CHEMBL649810,B,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,CHEMBL1134363,KI,Fc1ccc2c(c1)C=C(CC1CN=CN1)CC2
CHEMBL353212,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,63.1,nM,CHEMBL649810,B,Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cell,CHEMBL1134363,KI,C1=NC[C@H](C[C@]23CCc4ccccc4C2C3)N1
CHEMBL555190,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.73,nM,CHEMBL647963,B,Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,CHEMBL1133436,KI,Cl.Cl.O=C(NCCCCCNC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
CHEMBL268758,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,77.8,nM,CHEMBL647960,B,Ancillary Binding affinity towards cloned human Alpha-2A adrenergic receptor,CHEMBL1134245,KI,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3scc(-c4ccccc4)c3c2=O)CC1
CHEMBL551711,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.18,nM,CHEMBL647963,B,Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,CHEMBL1133436,KI,Cl.Cl.O=C(NCCCCCCCCCCCCNC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
CHEMBL538808,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.76,nM,CHEMBL647963,B,Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,CHEMBL1133436,KI,Cl.Cl.O=C(NCCCCCCCCNC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
CHEMBL540594,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,52.0,nM,CHEMBL647963,B,Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,CHEMBL1133436,KI,Cl.Cl.O=C(NCCCNC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
CHEMBL539824,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,15.3,nM,CHEMBL647963,B,Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,CHEMBL1133436,KI,Cl.Cl.O=C(NCCCCNC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
CHEMBL554019,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.39,nM,CHEMBL647963,B,Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,CHEMBL1133436,KI,Cl.Cl.O=C(NCCCCCCCCCCNC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
CHEMBL539606,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.25,nM,CHEMBL647963,B,Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,CHEMBL1133436,KI,Cl.Cl.O=C(NCCCCCCCCCNC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
CHEMBL542520,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,26.4,nM,CHEMBL647963,B,Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,CHEMBL1133436,KI,Cl.Cl.O=C(NCCNC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
CHEMBL543232,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.87,nM,CHEMBL647963,B,Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,CHEMBL1133436,KI,Cl.Cl.O=C(NCCCCCCCNC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
CHEMBL13856,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,82.5,nM,CHEMBL647960,B,Ancillary Binding affinity towards cloned human Alpha-2A adrenergic receptor,CHEMBL1134245,KI,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3scc(-c4cccc(C)c4)c3c2=O)CC1
CHEMBL15245,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.42,nM,CHEMBL647963,B,Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,CHEMBL1133436,KI,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
CHEMBL542527,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.35,nM,CHEMBL647963,B,Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,CHEMBL1133436,KI,Cl.Cl.O=C(NCCCCCCNC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
CHEMBL707,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,729.0,nM,CHEMBL647728,B,"Binding affinity against Alpha-2A adrenergic receptor, from human clones.",CHEMBL1128530,KI,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
CHEMBL315392,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,954.99,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)N(C)C)=C(C)N1
CHEMBL88448,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,676.08,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)N(C)CCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
CHEMBL279516,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2240.0,nM,CHEMBL647727,B,The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.,CHEMBL1128530,KI,O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1
CHEMBL314960,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2137.96,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)cc1
CHEMBL327931,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,109.65,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(Cl)c([N+](=O)[O-])c1
CHEMBL315538,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2187.76,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC)cc1
CHEMBL91956,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,446.68,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
CHEMBL313160,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,630.96,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])c(OC)c1
CHEMBL420060,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,612.0,nM,CHEMBL647727,B,The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.,CHEMBL1128530,KI,COc1ccccc1N1CCN(CCCNc2c(C)c(=O)n(C)c(=O)n2C)CC1
CHEMBL89243,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,758.58,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C#N)cc1
CHEMBL92322,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1584.89,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2ccccc2c1
CHEMBL5483012,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1202.26,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1.Cl
CHEMBL327775,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,630.96,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CC1=C(C#N)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1
CHEMBL88628,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2089.3,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2
CHEMBL25554,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3.5,nM,CHEMBL647728,B,"Binding affinity against Alpha-2A adrenergic receptor, from human clones.",CHEMBL1128530,KI,COc1cccc(OC)c1OCCNCC1COc2ccccc2O1
CHEMBL597,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2.6,nM,CHEMBL647727,B,The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.,CHEMBL1128530,KI,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1
CHEMBL313251,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1174.9,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CC1=C(C(=O)O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1
CHEMBL114166,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,114.0,nM,CHEMBL647728,B,"Binding affinity against Alpha-2A adrenergic receptor, from human clones.",CHEMBL1128530,KI,CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2
CHEMBL611,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3702.0,nM,CHEMBL647728,B,"Binding affinity against Alpha-2A adrenergic receptor, from human clones.",CHEMBL1128530,KI,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC
CHEMBL327712,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,912.01,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)c(Cl)c1
CHEMBL91415,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1122.02,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2
CHEMBL2,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2133.0,nM,CHEMBL647728,B,"Binding affinity against Alpha-2A adrenergic receptor, from human clones.",CHEMBL1128530,KI,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
CHEMBL91022,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,275.42,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
CHEMBL284103,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,398.11,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
CHEMBL313953,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,676.08,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CC(C)C1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C(C)C)N1
CHEMBL88388,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,954.99,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2
CHEMBL279436,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,151.36,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1
CHEMBL315914,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1288.25,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C)cc1
CHEMBL611,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,549.54,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC
CHEMBL312871,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,501.19,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CC1=C(C(N)=O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1
CHEMBL279436,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,302.0,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1
CHEMBL69733,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,100.0,nM,CHEMBL859451,B,Compound was evaluated for binding affinity against Alpha-2A adrenergic receptor using radioligand binding assay,CHEMBL1153669,KI,COc1ccc(CCCN2CCC(CCC(=O)c3cc(Cl)c(N)c4c3OCCO4)CC2)cc1OC
CHEMBL91550,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,354.81,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CC)N1
CHEMBL279436,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,371.54,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1
CHEMBL89685,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,602.56,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
CHEMBL284470,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,645.65,nM,CHEMBL643231,B,Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor,CHEMBL1131023,KI,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
CHEMBL1076,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1445.44,nM,CHEMBL643232,B,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CHEMBL1148329,KI,COc1ccc(OC)c(C(O)CN)c1
CHEMBL111496,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,131.83,nM,CHEMBL643232,B,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CHEMBL1148329,KI,CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1
CHEMBL109848,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,549.54,nM,CHEMBL643232,B,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CHEMBL1148329,KI,CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1
CHEMBL61006,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,275.42,nM,CHEMBL643232,B,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CHEMBL1148329,KI,CC(N)C(O)c1ccccc1
CHEMBL323402,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,72.44,nM,CHEMBL643232,B,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CHEMBL1148329,KI,Nc1cccc2c1CCCC2c1c[nH]cn1
CHEMBL111554,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,104.71,nM,CHEMBL643232,B,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CHEMBL1148329,KI,CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1
CHEMBL109783,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,33.11,nM,CHEMBL643232,B,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CHEMBL1148329,KI,CS(=O)(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1
CHEMBL111771,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,97.72,nM,CHEMBL643232,B,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CHEMBL1148329,KI,CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1
CHEMBL326702,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,169.82,nM,CHEMBL643232,B,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CHEMBL1148329,KI,CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1
CHEMBL317912,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,8.71,nM,CHEMBL643232,B,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CHEMBL1148329,KI,Oc1cccc2c1CCCC2c1c[nH]cn1
CHEMBL327116,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,22.91,nM,CHEMBL643232,B,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CHEMBL1148329,KI,CCS(=O)(=O)Nc1ccc2c(c1)C(c1c[nH]cn1)CCC2
CHEMBL108804,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,44.67,nM,CHEMBL643232,B,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CHEMBL1148329,KI,CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1
CHEMBL110751,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,309.03,nM,CHEMBL643232,B,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CHEMBL1148329,KI,O=C(Nc1cccc2c1CCCC2c1c[nH]cn1)C(F)(F)F
CHEMBL111463,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,85.11,nM,CHEMBL643232,B,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CHEMBL1148329,KI,CN(c1cccc2c1CCCC2c1c[nH]cn1)S(C)(=O)=O
CHEMBL321644,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,954.99,nM,CHEMBL643232,B,In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay,CHEMBL1148329,KI,O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1
CHEMBL294649,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,7943.28,nM,CHEMBL645791,B,Binding affinity against Alpha-2A adrenergic receptor,CHEMBL1128795,KI,Cn1cc(C(=O)C(=O)N[C@H]2CN3CCC2CC3)c2ccccc21
CHEMBL25467,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,24.0,nM,CHEMBL647721,B,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,CHEMBL1128729,KI,C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3
CHEMBL123448,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,31.0,nM,CHEMBL647721,B,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,CHEMBL1128729,KI,CCc1sc2ccc(Cl)c3c2c1CN(C)CC3
CHEMBL298612,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,31622.78,nM,CHEMBL645791,B,Binding affinity against Alpha-2A adrenergic receptor,CHEMBL1128795,KI,Cn1cc(C(=O)C(=O)N[C@@H]2CN3CCC2CC3)c2ccccc21
CHEMBL3559672,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,8.2,nM,CHEMBL647721,B,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,CHEMBL1128729,KI,
CHEMBL279436,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,148.0,nM,CHEMBL647721,B,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,CHEMBL1128729,KI,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1
CHEMBL5483012,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3300.0,nM,CHEMBL647721,B,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,CHEMBL1128729,KI,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1.Cl
CHEMBL114166,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,114.0,nM,CHEMBL647721,B,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,CHEMBL1128729,KI,CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2
CHEMBL3392246,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1023.0,nM,CHEMBL647721,B,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,CHEMBL1128729,KI,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
CHEMBL405355,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,645.0,nM,CHEMBL647721,B,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,CHEMBL1128729,KI,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1cccc([N+](=O)[O-])c1
CHEMBL15245,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,7.5,nM,CHEMBL647721,B,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,CHEMBL1128729,KI,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
CHEMBL122404,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,106.0,nM,CHEMBL647721,B,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,CHEMBL1128729,KI,COC(=O)C1=CO[C@@H](C)[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@H]12
CHEMBL3392247,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1550.0,nM,CHEMBL647721,B,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,CHEMBL1128729,KI,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1
CHEMBL284103,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,398.0,nM,CHEMBL647721,B,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,CHEMBL1128729,KI,CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
CHEMBL123138,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,54.0,nM,CHEMBL647721,B,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,CHEMBL1128729,KI,CN1CCc2c(Cl)ccc3oc(Br)c(c23)C1
CHEMBL10347,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4.6,nM,CHEMBL647721,B,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,CHEMBL1128729,KI,COC(=O)[C@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@H]2CC[C@@H]1O
CHEMBL123349,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,9.4,nM,CHEMBL647721,B,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,CHEMBL1128729,KI,CN1CCc2cccc(Cl)c2CC1
CHEMBL31410,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1218.0,nM,CHEMBL647721,B,Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor,CHEMBL1128729,KI,COC(=O)[C@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
CHEMBL71479,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3890.45,nM,CHEMBL640501,B,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CHEMBL1135421,KI,Cc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1
CHEMBL70740,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,794.33,nM,CHEMBL640501,B,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CHEMBL1135421,KI,O=S1(=O)CCCc2cccc(NCC3=NCCN3)c21
CHEMBL74114,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,870.96,nM,CHEMBL640501,B,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CHEMBL1135421,KI,CS(=O)(=O)c1cccc(F)c1NCC1=NCCN1
CHEMBL544290,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,5623.41,nM,CHEMBL640501,B,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CHEMBL1135421,KI,CS(=O)(=O)c1ccccc1NCC1=NCCN1.Cl
CHEMBL70692,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,165.96,nM,CHEMBL640501,B,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CHEMBL1135421,KI,CSc1c(F)cccc1NCC1=NCCN1
CHEMBL540035,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,81.28,nM,CHEMBL640501,B,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CHEMBL1135421,KI,CCSc1ccccc1NCC1=NCCN1.Cl
CHEMBL306792,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,58.88,nM,CHEMBL640501,B,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CHEMBL1135421,KI,CSc1cc(F)ccc1NCC1=NCCN1
CHEMBL74467,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4466.84,nM,CHEMBL640501,B,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CHEMBL1135421,KI,CS(=O)(=O)c1ccc(F)cc1NCC1=NCCN1
CHEMBL70973,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1318.26,nM,CHEMBL640501,B,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CHEMBL1135421,KI,CCS(=O)(=O)c1ccccc1NCC1=NCCN1
CHEMBL553276,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,81.28,nM,CHEMBL640501,B,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CHEMBL1135421,KI,CC(C)Sc1ccccc1NCC1=NCCN1.Cl
CHEMBL70691,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,218.78,nM,CHEMBL640501,B,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CHEMBL1135421,KI,COc1ccc(SC)c(NCC2=NCCN2)c1
CHEMBL70751,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,41.69,nM,CHEMBL640501,B,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CHEMBL1135421,KI,CSc1ccc(Cl)cc1NCC1=NCCN1
CHEMBL72724,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,199.53,nM,CHEMBL640501,B,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CHEMBL1135421,KI,CSc1ccc(C(F)(F)F)cc1NCC1=NCCN1
CHEMBL71001,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3630.78,nM,CHEMBL640501,B,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CHEMBL1135421,KI,COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1
CHEMBL74071,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2951.21,nM,CHEMBL640501,B,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CHEMBL1135421,KI,CC(C)S(=O)(=O)c1ccccc1NCC1=NCCN1
CHEMBL70563,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,5011.87,nM,CHEMBL640501,B,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CHEMBL1135421,KI,CS(=O)(=O)c1cc(Cl)ccc1NCC1=NCCN1
CHEMBL72441,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,63.1,nM,CHEMBL640501,B,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CHEMBL1135421,KI,CSc1ccc(C)cc1NCC1=NCCN1
CHEMBL72768,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,18.2,nM,CHEMBL640501,B,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CHEMBL1135421,KI,CSc1ccc(F)cc1NCC1=NCCN1
CHEMBL540542,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,47.86,nM,CHEMBL640501,B,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CHEMBL1135421,KI,CSc1ccccc1NCC1=NCCN1.Cl
CHEMBL542402,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,977.24,nM,CHEMBL640501,B,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CHEMBL1135421,KI,C[S+]([O-])c1ccccc1NCC1=NCCN1.Cl
CHEMBL762,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,16.22,nM,CHEMBL640501,B,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CHEMBL1135421,KI,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1
CHEMBL70326,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,398.11,nM,CHEMBL640501,B,Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,CHEMBL1135421,KI,CS(=O)(=O)c1cc(F)ccc1NCC1=NCCN1
CHEMBL179334,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1300.0,nM,CHEMBL647959,B,Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor,CHEMBL1128349,KI,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1ccc([N+](=O)[O-])cc1
CHEMBL5483012,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1100.0,nM,CHEMBL647959,B,Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor,CHEMBL1128349,KI,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1.Cl
CHEMBL2051956,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,900.0,nM,CHEMBL647959,B,Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor,CHEMBL1128349,KI,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@@H]1c1cccc([N+](=O)[O-])c1
CHEMBL611,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,550.0,nM,CHEMBL647959,B,Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor,CHEMBL1128349,KI,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC
CHEMBL2,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,210.0,nM,CHEMBL647959,B,Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor,CHEMBL1128349,KI,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
CHEMBL405355,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,530.0,nM,CHEMBL647959,B,Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor,CHEMBL1128349,KI,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1cccc([N+](=O)[O-])c1
CHEMBL290860,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,800.0,nM,CHEMBL647959,B,Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor,CHEMBL1128349,KI,CO/C(O)=C1\C(C)=NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
CHEMBL5483012,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1200.0,nM,CHEMBL647959,B,Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor,CHEMBL1128349,KI,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1.Cl
CHEMBL328631,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,9.3,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccc(F)cc4F)CC3)[C@@H]1CO2
CHEMBL98889,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,22.0,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccnc4)CC3)[C@@H]1CO2
CHEMBL328114,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,8.8,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2
CHEMBL95218,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,5.9,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4cccc(F)c4)CC3)[C@@H]1CO2
CHEMBL419894,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,9.0,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccc(F)cc4)CC3)[C@@H]1CO2
CHEMBL101411,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,69.0,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccc(Cl)cc4)CC3)[C@@H]1CO2
CHEMBL101361,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,5.2,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4OC)CC3)[C@@H]1CO2
CHEMBL419336,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3.0,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccc(F)c4F)CC3)[C@@H]1CO2
CHEMBL99916,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.7,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccco4)CC3)[C@@H]1CO2
CHEMBL98646,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.7,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccs4)CC3)[C@@H]1CO2
CHEMBL101596,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.1,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccsc4)CC3)[C@@H]1CO2
CHEMBL328195,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.4,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccsc4)CC3)[C@@H]1CO2
CHEMBL319573,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2.9,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4F)CC3)[C@@H]1CO2
CHEMBL319119,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.3,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cc(F)ccc4F)CC3)[C@@H]1CO2
CHEMBL329065,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.9,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccc(O)cc4)CC3)[C@@H]1CO2
CHEMBL318235,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3.4,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2
CHEMBL98541,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2.9,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccc(F)cc4)CC3)[C@@H]1CO2
CHEMBL91157,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.8,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2
CHEMBL419316,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.3,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2
CHEMBL99868,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.0,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1ccccc1/C=C(\C)CN1CCN(C[C@@H]2ON=C3c4cc(OC)c(OC)cc4OC[C@H]32)CC1
CHEMBL100879,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.3,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4cccs4)CC3)[C@@H]1CO2
CHEMBL263424,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.1,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccc(F)c4)CC3)[C@@H]1CO2
CHEMBL420830,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,23.0,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C\c4ccccc4)CC3)[C@@H]1CO2
CHEMBL319530,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.5,nM,CHEMBL647724,B,In vitro binding affinity to the human alpha-2A adrenergic receptor,CHEMBL1146766,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccco4)CC3)[C@@H]1CO2
CHEMBL836,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,63.0,nM,CHEMBL647966,B,Binding affinity towards recombinant human alpha-2A adrenergic receptor was determined using [3H]MK-912 as radioligand,CHEMBL1133729,KI,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1
CHEMBL6310,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1370.0,nM,CHEMBL647969,B,Binding affinity towards alpha-2A-Adrenergic receptor,CHEMBL1144986,KI,COc1ccc2c3c([nH]c2c1)CNCC3
CHEMBL269538,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2540.0,nM,CHEMBL647969,B,Binding affinity towards alpha-2A-Adrenergic receptor,CHEMBL1144986,KI,COc1ccc2c(c1)[nH]c1c(C)nccc12
CHEMBL19236,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,150.0,nM,CHEMBL647962,B,Binding affinity for human Alpha-2A adrenergic receptor,CHEMBL1129518,KI,COc1nc(C)nc(Cl)c1NC1=NCCN1
CHEMBL1437,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,66.0,nM,CHEMBL647962,B,Binding affinity for human Alpha-2A adrenergic receptor,CHEMBL1129518,KI,NC[C@H](O)c1ccc(O)c(O)c1
CHEMBL134,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3.8,nM,CHEMBL647962,B,Binding affinity for human Alpha-2A adrenergic receptor,CHEMBL1129518,KI,Clc1cccc(Cl)c1NC1=NCCN1
CHEMBL316495,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,955.0,nM,CHEMBL873181,B,Binding affinity against human Alpha-2a adrenergic receptor,CHEMBL1132000,KI,CCCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCC)=C(CC)N1
CHEMBL320736,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2308.0,nM,CHEMBL873181,B,Binding affinity against human Alpha-2a adrenergic receptor,CHEMBL1132000,KI,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCC(F)(F)F)N1
CHEMBL133231,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.6,nM,CHEMBL648169,B,Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand,CHEMBL1128460,KI,NC1=NC2(CCc3cccc(Cl)c3C2)CO1
CHEMBL95578,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,813.0,nM,CHEMBL873181,B,Binding affinity against human Alpha-2a adrenergic receptor,CHEMBL1132000,KI,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCCN)N1
CHEMBL336332,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,12.0,nM,CHEMBL648169,B,Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand,CHEMBL1128460,KI,COc1cccc2c1CCC1(CN=CN1)C2
CHEMBL180561,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,369.0,nM,CHEMBL873181,B,Binding affinity against human Alpha-2a adrenergic receptor,CHEMBL1132000,KI,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1
CHEMBL131220,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,12.0,nM,CHEMBL648169,B,Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand,CHEMBL1128460,KI,Fc1cccc2c1CC1(CC2)CN=CN1
CHEMBL338683,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3.0,nM,CHEMBL648169,B,Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand,CHEMBL1128460,KI,Clc1cc(Cl)c2c(c1)CC1(CC2)CN=CN1
CHEMBL98063,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,468.0,nM,CHEMBL647961,B,Binding affinity against human Alpha-2A adrenergic receptor,CHEMBL1132000,KI,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN=[N+]=[N-])N1
CHEMBL133579,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,51.0,nM,CHEMBL648169,B,Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand,CHEMBL1128460,KI,COc1ccc2c(c1)CC1(CC2)CN=CN1
CHEMBL323579,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,403.0,nM,CHEMBL873181,B,Binding affinity against human Alpha-2a adrenergic receptor,CHEMBL1132000,KI,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1
CHEMBL100045,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,575.0,nM,CHEMBL873181,B,Binding affinity against human Alpha-2a adrenergic receptor,CHEMBL1132000,KI,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COC)N1
CHEMBL336970,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,87.0,nM,CHEMBL648169,B,Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand,CHEMBL1128460,KI,COc1ccc2c(c1)CCC1(CN=CN1)C2
CHEMBL98471,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,7.0,nM,CHEMBL648169,B,Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand,CHEMBL1128460,KI,Cc1ccc2c(c1)CC1(CC2)CN=CN1
CHEMBL130853,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,34.0,nM,CHEMBL648169,B,Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand,CHEMBL1128460,KI,C1=NCC2(CCc3ccccc3C2)N1
CHEMBL99864,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,99.0,nM,CHEMBL873181,B,Binding affinity against human Alpha-2a adrenergic receptor,CHEMBL1132000,KI,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCOC)N1
CHEMBL131417,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,51.0,nM,CHEMBL648169,B,Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand,CHEMBL1128460,KI,COc1cccc2c1CC1(CC2)CN=CN1
CHEMBL5483012,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2417.0,nM,CHEMBL873181,B,Binding affinity against human Alpha-2a adrenergic receptor,CHEMBL1132000,KI,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1.Cl
CHEMBL95290,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1698.0,nM,CHEMBL873181,B,Binding affinity against human Alpha-2a adrenergic receptor,CHEMBL1132000,KI,CCNC(=O)C1=C(CC)NC(COCCN)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
CHEMBL101340,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1560.0,nM,CHEMBL648169,B,Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand,CHEMBL1128460,KI,FC(F)(F)c1ccc(Cl)c(NC2=NCCN2)c1
CHEMBL1788223,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,872.0,nM,CHEMBL647970,B,Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin,CHEMBL1131058,KI,COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4N=C(SC)N32)CC1
CHEMBL1788222,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,444.0,nM,CHEMBL647970,B,Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin,CHEMBL1131058,KI,COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4NC(=O)N32)CC1
CHEMBL302021,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,547.0,nM,CHEMBL647970,B,Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin,CHEMBL1131058,KI,COc1ccccc1N1CCN(CC2CN3C(=O)Nc4ccccc4C3=N2)CC1
CHEMBL51433,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1811.0,nM,CHEMBL647970,B,Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin,CHEMBL1131058,KI,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1
CHEMBL2092927,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3000.0,nM,CHEMBL647970,B,Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin,CHEMBL1131058,KI,COc1ccccc1N1CCN(C[C@@H]2CN=C3c4ccccc4N=C(SC)N32)CC1
CHEMBL295186,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,13.8,nM,CHEMBL643234,B,Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine,CHEMBL1132926,KI,c1ccc(C[C@H]2C3CCC(C3)[C@H]2NC2=NCCO2)cc1
CHEMBL50720,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,15.14,nM,CHEMBL643234,B,Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine,CHEMBL1132926,KI,c1ccc(CCC[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1
CHEMBL47313,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.445,nM,CHEMBL643234,B,Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine,CHEMBL1132926,KI,c1ccc(CC[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1
CHEMBL297752,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2.951,nM,CHEMBL643234,B,Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine,CHEMBL1132926,KI,CCC[C@H]1CCCC[C@@H]1NC1=NCCO1
CHEMBL297228,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,18.2,nM,CHEMBL643234,B,Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine,CHEMBL1132926,KI,c1ccc([C@H]2CCCC[C@@H]2NC2=NCCO2)cc1
CHEMBL50719,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,20.89,nM,CHEMBL643234,B,Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine,CHEMBL1132926,KI,c1ccc(C[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1
CHEMBL297827,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,15.85,nM,CHEMBL643234,B,Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine,CHEMBL1132926,KI,C(=C/c1ccccc1)\C[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1
CHEMBL48341,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,30.9,nM,CHEMBL643234,B,Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine,CHEMBL1132926,KI,c1ccc(CCC[C@H]2C3CCC(C3)[C@H]2NC2=NCCO2)cc1
CHEMBL296660,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,28.18,nM,CHEMBL643234,B,Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine,CHEMBL1132926,KI,CCC[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1
CHEMBL93171,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.8,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CO2
CHEMBL77913,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,10.0,nM,CHEMBL647965,B,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,CHEMBL1130342,KI,COc1ccc(Nc2ncc[nH]2)c(C)c1
CHEMBL90997,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,5.9,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,Fc1ccc2c(c1)CC(CC1CN=CN1)C2
CHEMBL308863,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,130.0,nM,CHEMBL647965,B,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,CHEMBL1130342,KI,COc1ccc(Nc2ncc[nH]2)c(C)c1OC
CHEMBL422597,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.8,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1ccc2c(c1)C1=NOC(CN3CCN(C/C=C/c4ccccc4)CC3)C1CO2
CHEMBL91157,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,16.0,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2
CHEMBL419316,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,30.0,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2
CHEMBL94435,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,98.0,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4cc5ccccc5s4)CC3)C1CO2
CHEMBL844,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2.7,nM,CHEMBL647965,B,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,CHEMBL1130342,KI,Brc1c(NC2=NCCN2)ccc2nccnc12
CHEMBL432155,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,6.0,nM,CHEMBL647965,B,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,CHEMBL1130342,KI,Cc1c(Nc2ncc[nH]2)ccc2c1NCCO2
CHEMBL93801,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,66.0,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4csc5ccccc45)CC3)C1CO2
CHEMBL91297,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,234.0,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4cccc5ccccc45)CC3)C1CO2
CHEMBL75491,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,31.0,nM,CHEMBL647965,B,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,CHEMBL1130342,KI,Cc1c(Nc2ncc[nH]2)ccc2nccnc12
CHEMBL92860,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,93.0,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2
CHEMBL74544,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,76.0,nM,CHEMBL647965,B,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,CHEMBL1130342,KI,c1c[nH]c(Nc2ccc3[nH]cnc3c2)n1
CHEMBL75257,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4.9,nM,CHEMBL647965,B,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,CHEMBL1130342,KI,COc1c(C(C)(C)C)cc(C)c(Nc2ncc[nH]2)c1C
CHEMBL328114,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2.6,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2
CHEMBL268258,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2.4,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cccc2c1CCC[C@H]2CN(C)CCc1ccc2ccoc2c1
CHEMBL420830,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,23.0,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C\c4ccccc4)CC3)[C@@H]1CO2
CHEMBL92496,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,234.0,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cc2c(cc1OC)C1=NOC(CN3CCN(CCc4ccccc4)CC3)C1CO2
CHEMBL91157,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.3,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2
CHEMBL90966,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,117.0,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccc5ncccc5c4)CC3)C1CO2
CHEMBL76457,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,210.0,nM,CHEMBL647965,B,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,CHEMBL1130342,KI,Brc1ccccc1Nc1ncc[nH]1
CHEMBL1019,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,510.0,nM,CHEMBL647965,B,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,CHEMBL1130342,KI,Brc1c(Nc2ncc[nH]2)ccc2nccnc12
CHEMBL1022,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,95.0,nM,CHEMBL647965,B,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,CHEMBL1130342,KI,Clc1cccc(Cl)c1Nc1ncc[nH]1
CHEMBL308570,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.7,nM,CHEMBL647965,B,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,CHEMBL1130342,KI,Cc1c(Nc2ncc[nH]2)ccc2c1OCCO2
CHEMBL49137,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2.0,nM,CHEMBL647965,B,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,CHEMBL1130342,KI,Cc1c(NC2=NCCN2)ccc2nccnc12
CHEMBL90419,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,26.0,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cc2c(cc1OC)C1=NOC(CN3CCN(CCCc4ccccc4)CC3)C1CO2
CHEMBL90247,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.5,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1ccc2c(c1)OCC1C2=NOC1CN1CCN(C/C=C/c2ccccc2)CC1
CHEMBL328735,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,12.0,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cc2c(cc1OC)C1=NOC(CN3CCN(CCC(=O)c4ccccc4)CC3)C1CO2
CHEMBL93489,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,8.8,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccccc4)CC3)C1CO2
CHEMBL327875,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.4,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C(\C)c4ccccc4)CC3)C1CO2
CHEMBL328114,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,25.0,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2
CHEMBL90943,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.9,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,C(=C/c1ccccc1)\CN1CCN(CC2ON=C3c4ccccc4OCC32)CC1
CHEMBL91824,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,34.0,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4cnc5ccccc5c4)CC3)C1CO2
CHEMBL92860,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.3,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2
CHEMBL90843,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,186.0,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccccc4)CC3)C1CO2
CHEMBL419316,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.3,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2
CHEMBL74449,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3100.0,nM,CHEMBL647965,B,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,CHEMBL1130342,KI,c1c[nH]c(Nc2ccc3nccnc3c2)n1
CHEMBL94129,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,5.0,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccc5ccccc5c4)CC3)C1CO2
CHEMBL328377,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,22.0,nM,CHEMBL647723,B,In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine,CHEMBL1136157,KI,COc1cc2c(cc1OC)C1=NOC(CN3CCN(CC4=Cc5ccccc5C4)CC3)C1CO2
CHEMBL78190,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,39.0,nM,CHEMBL647965,B,Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells,CHEMBL1130342,KI,COc1cc(C)c(Nc2ncc[nH]2)cc1C(C)(C)C
CHEMBL147077,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,760.0,nM,CHEMBL647967,B,Binding affinity for recombinant human Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand.,CHEMBL1131441,KI,CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
CHEMBL288772,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4519.0,nM,CHEMBL645789,B,In vivo inhibitory effect against Alpha-2A adrenergic receptor,CHEMBL1133242,KI,CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C
CHEMBL42335,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,7852.0,nM,CHEMBL645789,B,In vivo inhibitory effect against Alpha-2A adrenergic receptor,CHEMBL1133242,KI,CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1
CHEMBL295395,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3388.0,nM,CHEMBL645789,B,In vivo inhibitory effect against Alpha-2A adrenergic receptor,CHEMBL1133242,KI,CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C
CHEMBL291166,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1862.0,nM,CHEMBL645789,B,In vivo inhibitory effect against Alpha-2A adrenergic receptor,CHEMBL1133242,KI,CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C
CHEMBL43491,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1288.0,nM,CHEMBL645789,B,In vivo inhibitory effect against Alpha-2A adrenergic receptor,CHEMBL1133242,KI,CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1
CHEMBL43594,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,13646.0,nM,CHEMBL645789,B,In vivo inhibitory effect against Alpha-2A adrenergic receptor,CHEMBL1133242,KI,CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C
CHEMBL43860,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,229.0,nM,CHEMBL645789,B,In vivo inhibitory effect against Alpha-2A adrenergic receptor,CHEMBL1133242,KI,CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1
CHEMBL295001,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1972.0,nM,CHEMBL645789,B,In vivo inhibitory effect against Alpha-2A adrenergic receptor,CHEMBL1133242,KI,CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1
CHEMBL74283,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,6.457,nM,CHEMBL643228,B,Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine,CHEMBL1128892,KI,Brc1c(NC2=NCCN2)ccc2c1NCCN2
CHEMBL72995,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3801.89,nM,CHEMBL643228,B,Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine,CHEMBL1128892,KI,CC1CN=C(Nc2ccc3nccnc3c2Br)N1
CHEMBL844,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,6.761,nM,CHEMBL643228,B,Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine,CHEMBL1128892,KI,Brc1c(NC2=NCCN2)ccc2nccnc12
CHEMBL72753,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,37.15,nM,CHEMBL643228,B,Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine,CHEMBL1128892,KI,Clc1c(NC2=NCCN2)ccc2nccnc12
CHEMBL49137,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,7.244,nM,CHEMBL643228,B,Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine,CHEMBL1128892,KI,Cc1c(NC2=NCCN2)ccc2nccnc12
CHEMBL74342,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,14791.08,nM,CHEMBL643228,B,Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine,CHEMBL1128892,KI,Brc1c(NC2=N[C@@H]3CCCC[C@@H]3N2)ccc2nccnc12
CHEMBL73164,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,26302.68,nM,CHEMBL643228,B,Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine,CHEMBL1128892,KI,Brc1c(NC2=NCCO2)ccc2nccnc12
CHEMBL49395,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,309.03,nM,CHEMBL643228,B,Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine,CHEMBL1128892,KI,c1cnc2cc(NC3=NCCN3)ccc2n1
CHEMBL70676,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,6.761,nM,CHEMBL643228,B,Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine,CHEMBL1128892,KI,Ic1c(NC2=NCCN2)ccc2nccnc12
CHEMBL73392,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,10232.93,nM,CHEMBL643228,B,Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine,CHEMBL1128892,KI,Brc1c(NC2=NCCS2)ccc2nccnc12
CHEMBL72147,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,74.13,nM,CHEMBL643228,B,Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine,CHEMBL1128892,KI,Cc1cnc2c(Br)c(NC3=NCCN3)ccc2n1
CHEMBL289480,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,181.97,nM,CHEMBL643229,B,Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine,CHEMBL1127980,KI,C1COC(NC(C2CC2)C2CC2)=N1
CHEMBL15245,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3.1,nM,CHEMBL647725,B,Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor,CHEMBL1132537,KI,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
CHEMBL75201,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,16595.87,nM,CHEMBL643229,B,Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine,CHEMBL1127980,KI,C1COC(N2CCOCC2)=N1
CHEMBL134,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,7.943,nM,CHEMBL643229,B,Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine,CHEMBL1127980,KI,Clc1cccc(Cl)c1NC1=NCCN1
CHEMBL75030,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2.344,nM,CHEMBL643229,B,Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine,CHEMBL1127980,KI,c1ccc2c(c1)CCCC2NC1=NCCO1
CHEMBL310335,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2.951,nM,CHEMBL643229,B,Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine,CHEMBL1127980,KI,CCC[C@H]1CCCCC1NC1=NCCO1
CHEMBL305928,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,5.37,nM,CHEMBL643229,B,Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine,CHEMBL1127980,KI,C1CCCC(NC2=NCCO2)CC1
CHEMBL306377,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,25.7,nM,CHEMBL643229,B,Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine,CHEMBL1127980,KI,c1ccc2c(c1)CCCC2NC1=NCCCO1
CHEMBL346389,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,411.0,nM,CHEMBL647725,B,Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor,CHEMBL1132537,KI,O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1
CHEMBL91157,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.3,nM,CHEMBL839642,B,Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor,CHEMBL1142735,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2
CHEMBL419316,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.3,nM,CHEMBL839642,B,Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor,CHEMBL1142735,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2
CHEMBL92860,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.3,nM,CHEMBL839642,B,Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor,CHEMBL1142735,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2
CHEMBL268258,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2.5,nM,CHEMBL839642,B,Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor,CHEMBL1142735,KI,COc1cccc2c1CCC[C@H]2CN(C)CCc1ccc2ccoc2c1
CHEMBL90997,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,5.9,nM,CHEMBL839642,B,Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor,CHEMBL1142735,KI,Fc1ccc2c(c1)CC(CC1CN=CN1)C2
CHEMBL328114,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2.6,nM,CHEMBL839642,B,Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor,CHEMBL1142735,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2
CHEMBL2112978,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.9,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,C(=C/c1ccccc1)\CN1CCN(C[C@@H]2ON=C3c4ccccc4OC[C@H]32)CC1
CHEMBL2112981,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,20.0,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,C(=C/c1ccccc1)\CN1CCN(C[C@@H]2ON=C3c4ccccc4NC[C@H]32)CC1
CHEMBL2112984,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4.0,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,c1ccc2c(c1)NC[C@@H]1C2=NO[C@H]1CN1CCN(Cc2ccc3ccccc3c2)CC1
CHEMBL2112970,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.6,nM,CHEMBL838833,B,Binding affinity for Alpha-2A adrenergic receptor,CHEMBL1142735,KI,CN1C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21
CHEMBL2112973,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,20.0,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,CCNC(=O)N1C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21
CHEMBL2112975,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,33.0,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,CCOC(=O)N1C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21
CHEMBL426959,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,47.0,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,CC(=O)N1C[C@@H]2C(=NO[C@H]2CN2CCN(CCC/C=C/c3ccccc3)CC2)c2ccccc21
CHEMBL2112983,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,7.9,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CN2
CHEMBL2112985,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2.4,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CN2
CHEMBL2112971,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,6.5,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CN2
CHEMBL2112976,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,74.0,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CN2
CHEMBL2112969,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,9.1,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(CCOc4ccc(F)cc4)CC3)[C@@H]1CN2
CHEMBL2112977,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,11.0,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,COc1cc2c(cc1OC)N(C)C[C@@H]1C2=NO[C@H]1CN1CCN(CCC/C(C)=C/c2ccccc2)CC1
CHEMBL2112979,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,43.0,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,C1=C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21
CHEMBL2112982,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.8,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,COc1ccc2c(c1)C=C[C@@H]1C2=NO[C@H]1CN1CCN(C/C=C/c2ccccc2)CC1
CHEMBL2112972,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.8,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,COc1ccc2c(c1)C=C[C@@H]1C2=NO[C@H]1CN1CCN(Cc2ccc3ccccc3c2)CC1
CHEMBL176002,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.5,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,COc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1
CHEMBL180470,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.2,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(O)cc4OC[C@H]32)CC1
CHEMBL435352,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.1,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,COCCOc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1
CHEMBL179237,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.3,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,CCOCCOCCOc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1
CHEMBL369378,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.3,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC5CCCC5)cc4OC[C@H]32)CC1
CHEMBL176261,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.1,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OCCN(C)C)cc4OC[C@H]32)CC1
CHEMBL176116,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.4,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,CC(=O)Oc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1
CHEMBL175853,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.7,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,COCC(=O)Oc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1
CHEMBL175911,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.9,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC(=O)C5CC5)cc4OC[C@H]32)CC1
CHEMBL180322,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.9,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,C=CC(=O)Oc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1
CHEMBL178588,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4.7,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC(=O)C(C)(C)C)cc4OC[C@H]32)CC1
CHEMBL425324,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.0,nM,CHEMBL838835,B,Binding affinity for alpha-2A adrenergic receptor,CHEMBL1142735,KI,C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC(=O)c5ccncc5)cc4OC[C@H]32)CC1
CHEMBL287837,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,6520.0,nM,CHEMBL839603,B,Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand,CHEMBL1144326,KI,Clc1ccc2c(c1Cl)CNCC2
CHEMBL26717,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3400.0,nM,CHEMBL839603,B,Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand,CHEMBL1144326,KI,NS(=O)(=O)c1ccc2c(c1)CNCC2
CHEMBL281289,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3200.0,nM,CHEMBL839603,B,Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand,CHEMBL1144326,KI,O=[N+]([O-])c1ccc2c(c1)CNCC2
CHEMBL59719,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4840.0,nM,CHEMBL839603,B,Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand,CHEMBL1144326,KI,CC1Cc2ccc([N+](=O)[O-])cc2CN1
CHEMBL59441,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3900.0,nM,CHEMBL839603,B,Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand,CHEMBL1144326,KI,O=[N+]([O-])c1ccc2c(c1)CNC(CO)C2
CHEMBL97282,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3200.0,nM,CHEMBL839603,B,Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand,CHEMBL1144326,KI,O=[N+]([O-])c1ccc2c(c1)CNC(CF)C2
CHEMBL182376,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3600.0,nM,CHEMBL839603,B,Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand,CHEMBL1144326,KI,O=[N+]([O-])c1ccc2c(c1)CNC(C(F)F)C2
CHEMBL112351,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3400.0,nM,CHEMBL839603,B,Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand,CHEMBL1144326,KI,O=[N+]([O-])c1ccc2c(c1)CNC(C(F)(F)F)C2
CHEMBL112964,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4350.0,nM,CHEMBL839603,B,Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand,CHEMBL1144326,KI,FC(F)(F)C1Cc2ccc(Br)cc2CN1
CHEMBL366164,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,156.0,nM,CHEMBL828756,B,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CHEMBL1142715,KI,CN(C)C[C@H]1C[C@@H]2c3ccccc3Sc3ccc(F)cc3[C@H]2O1
CHEMBL329566,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,126.0,nM,CHEMBL828756,B,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CHEMBL1142715,KI,CN(C)C[C@H]1C[C@@H]2c3ccccc3Cc3ccccc3[C@H]2O1
CHEMBL42,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,24.0,nM,CHEMBL828756,B,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CHEMBL1142715,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL715,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,192.0,nM,CHEMBL828756,B,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CHEMBL1142715,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL85,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,10.0,nM,CHEMBL828756,B,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CHEMBL1142715,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL654,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,20.0,nM,CHEMBL828756,B,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CHEMBL1142715,KI,CN1CCN2c3ncccc3Cc3ccccc3C2C1
CHEMBL6437,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4.8,nM,CHEMBL828756,B,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CHEMBL1142715,KI,CN1CCN2c3ccccc3Cc3ccccc3C2C1
CHEMBL195706,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,251.0,nM,CHEMBL828756,B,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CHEMBL1142715,KI,CN(C)C[C@@H]1CC2c3ccccc3Oc3ccc(F)cc3[C@H]2O1
CHEMBL194659,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,269.0,nM,CHEMBL828756,B,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CHEMBL1142715,KI,CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(F)cc3[C@H]2O1
CHEMBL364270,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,302.0,nM,CHEMBL828756,B,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CHEMBL1142715,KI,CN(C)C[C@@H]1CC2c3ccccc3Oc3ccc(Cl)cc3[C@H]2O1
CHEMBL435301,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,10.0,nM,CHEMBL828756,B,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CHEMBL1142715,KI,CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(Cl)cc3[C@H]2O1
CHEMBL193435,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,407.0,nM,CHEMBL828756,B,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CHEMBL1142715,KI,CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(Br)cc3[C@H]2O1
CHEMBL363581,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,72.0,nM,CHEMBL828756,B,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CHEMBL1142715,KI,CN(C)C[C@@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1
CHEMBL193639,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,66.0,nM,CHEMBL828756,B,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CHEMBL1142715,KI,CN(C)C[C@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1
CHEMBL193639,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,79.0,nM,CHEMBL828756,B,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CHEMBL1142715,KI,CN(C)C[C@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1
CHEMBL15245,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.4,nM,CHEMBL839549,B,In vitro binding affinity towards alpha-2a adrenergic receptor,CHEMBL1145270,KI,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
CHEMBL196451,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,29.0,nM,CHEMBL839549,B,In vitro binding affinity towards alpha-2a adrenergic receptor,CHEMBL1145270,KI,O=C(CCCNC(=O)[C@@H]1C2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)OCc1ccccc1
CHEMBL597,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,55.9,nM,CHEMBL884796,B,Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells,CHEMBL1143453,KI,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1
CHEMBL362954,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,6.3,nM,CHEMBL884796,B,Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells,CHEMBL1143453,KI,COc1cccc(N(NC2=NCCN2)c2ccc(C)cc2)c1
CHEMBL194849,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,23.8,nM,CHEMBL884796,B,Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells,CHEMBL1143453,KI,Cc1ccc(N(NC2=NCCN2)c2cccc(O)c2)cc1
CHEMBL370818,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4.73,nM,CHEMBL884796,B,Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells,CHEMBL1143453,KI,Cc1ccc(N(NC2=NCCO2)c2cccc(O)c2)cc1
CHEMBL199824,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1012.0,nM,CHEMBL869447,B,Binding affinity to adrenergic alpha-2A receptor,CHEMBL1148600,KI,Cn1c(=O)cnn(CCCCN2CCN(c3cccc4ccc(O[11CH3])cc34)CC2)c1=O
CHEMBL371300,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2270.0,nM,CHEMBL863553,B,Displacement of [3H]clonidine from cloned human adrenergic alpha2A receptor expressed in Sf9 cells,CHEMBL1148572,KI,C[C@H](N)Cn1ncc2ccc(O)cc21
CHEMBL426317,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,250.0,nM,CHEMBL861835,B,Binding affinity to alpha 2A adrenergic receptor by radioligand binding assay,CHEMBL1146943,KI,COc1cccc(N2CCN(CCCCn3ncc(=O)n(C)c3=O)CC2)c1
CHEMBL150161,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2239.0,nM,CHEMBL862622,B,Binding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assay,CHEMBL1148503,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1
CHEMBL210578,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2835.0,nM,CHEMBL862622,B,Binding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assay,CHEMBL1148503,KI,O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1
CHEMBL150161,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,5817.0,nM,CHEMBL862622,B,Binding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assay,CHEMBL1148503,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1
CHEMBL212912,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,455.0,nM,CHEMBL870476,B,Binding affinity at adrenergic alpha2A receptor,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1
CHEMBL213834,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,882.0,nM,CHEMBL870476,B,Binding affinity at adrenergic alpha2A receptor,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc4ccccc34)c3ccccc32)CC1
CHEMBL213424,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,456.0,nM,CHEMBL870476,B,Binding affinity at adrenergic alpha2A receptor,CHEMBL1146871,KI,Cc1cccc(N)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL213336,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,791.0,nM,CHEMBL870476,B,Binding affinity at adrenergic alpha2A receptor,CHEMBL1146871,KI,Cc1cccc(C)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL378669,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,327.0,nM,CHEMBL870476,B,Binding affinity at adrenergic alpha2A receptor,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(N)cccc3Cl)c3ccccc32)CC1
CHEMBL213492,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2000.0,nM,CHEMBL870476,B,Binding affinity at adrenergic alpha2A receptor,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(F)cccc3C(F)(F)F)c3ccccc32)CC1
CHEMBL425069,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,169.0,nM,CHEMBL870476,B,Binding affinity at adrenergic alpha2A receptor,CHEMBL1146871,KI,COc1cccc(OC)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL106525,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3200.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,CN1CCN(c2ccc(Nc3c4ccccc4nc4ccccc34)cc2)CC1
CHEMBL217366,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3600.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,CCN1CCN(c2ccc(Nc3c4ccccc4nc4ccccc34)cc2)CC1
CHEMBL217768,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,630.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,CCc1c(C)nc2c(c1Nc1ccc(N3CCN(C)C(C)C3)cc1)CCCC2
CHEMBL217180,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3600.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1cncc(C)c1Nc1ccc(N2CCN(C)CC2)cc1
CHEMBL216399,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,500.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1cc(Nc2ccc(N3CCN(C)CC3)cc2)c2ccccc2n1
CHEMBL384925,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,580.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1Cc1ccccc1
CHEMBL216290,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1700.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1-c1ccccc1
CHEMBL425622,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1700.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1C(C)C
CHEMBL425803,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1100.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,CCc1c(C)nc2ccccc2c1Nc1ccc(N2CCN(C)CC2)cc1
CHEMBL267464,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2210.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1C
CHEMBL217665,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,720.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,CN1CCN(c2ccc(Nc3ccnc4ccccc34)cc2)CC1
CHEMBL216727,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1230.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1nc2ccc(F)cc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C
CHEMBL217568,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,775.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1nc2cccc(Cl)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C
CHEMBL1689423,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1430.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1nc2cc(Cl)ccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C
CHEMBL384318,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2300.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1nc2c(C)ccc(C)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C
CHEMBL218730,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,650.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1cc(C)c2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1
CHEMBL217452,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,680.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1nc2cccc(C)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C
CHEMBL217177,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1900.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1nc2c(C)cccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C
CHEMBL217278,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1050.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1ccc2c(Nc3ccc(N4CCN(C)[C@@H](C)C4)cc3)c(C)c(C)nc2c1
CHEMBL383978,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,910.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1ccc2c(Nc3ccc(N4CCN(C)[C@H](C)C4)cc3)c(C)c(C)nc2c1
CHEMBL262901,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,840.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1ccc2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1
CHEMBL216674,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,850.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1ccc2c(Nc3ccc(N4CCN(C)[C@@H](C)C4)cc3)c(C)c(C)nc2c1C
CHEMBL217567,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,790.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1ccc2c(Nc3ccc(N4CCN(C)[C@H](C)C4)cc3)c(C)c(C)nc2c1C
CHEMBL217203,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1850.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1ccc2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1C
CHEMBL217202,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1400.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1cnc2ccccc2c1Nc1ccc(N2CCN(C)C(C)C2)cc1
CHEMBL218679,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,895.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1cnc2ccccc2c1Nc1ccc(N2CCN(C)C(C)(C)C2)cc1
CHEMBL425983,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,715.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1nc2ccccc2c(Nc2ccc(N3CCN4CCCCC4C3)cc2)c1C
CHEMBL218457,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1400.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1-c1ccccc1
CHEMBL386169,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,8000.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,CCc1c(C)nc2c(C)cccc2c1Nc1ccc(N2CCCN(C)CC2)cc1
CHEMBL440594,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1000.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1nc2ccccc2c(Nc2ccc(NCCN3CCCC3)cc2)c1C
CHEMBL216197,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,900.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,CCc1c(C)nc2c(C)cccc2c1Nc1ccc(NCCN(CC)CC)cc1
CHEMBL214661,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,980.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccc(F)cc34)cc2)CCN1C
CHEMBL424917,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1320.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,CN1CCN(c2ccc(Nc3c(CO)cnc4ccc(F)cc34)cc2)CC1(C)C
CHEMBL276417,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1380.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,CC1CN(c2ccc(Nc3c(CO)cnc4ccc(F)cc34)cc2)CCN1C
CHEMBL216464,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,960.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,CN1CCN(c2ccc(Nc3c(CO)cnc4cc(Cl)ccc34)cc2)CC1(C)C
CHEMBL385722,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,9600.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CCN1
CHEMBL217542,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2200.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CCN1C
CHEMBL268217,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1850.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,CN1CCN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CC1(C)C
CHEMBL217254,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1870.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1c(CO)nc2ccccc2c1Nc1ccc(N2CCN(C)[C@H](C)C2)cc1
CHEMBL217253,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3100.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C(C)O
CHEMBL218675,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1170.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)(C)C3)cc2)c1CO
CHEMBL214996,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3100.0,nM,CHEMBL856624,B,Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells,CHEMBL1137309,KI,Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1CO
CHEMBL217299,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,180.0,nM,CHEMBL911251,B,Binding affinity to human cloned adrenergic alpha 2A receptor,CHEMBL1137342,KI,Oc1cc2c(cc1O)C1c3ccccc3CNC1CO2
CHEMBL128168,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,47.86,nM,CHEMBL918089,B,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1149245,KI,CC(Oc1ccccc1-c1ccccc1)C1=NCCN1
CHEMBL221989,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1202.26,nM,CHEMBL918089,B,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1149245,KI,CC(Oc1ccccc1-c1ccccn1)C1=NCCN1
CHEMBL222593,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,8128.31,nM,CHEMBL918089,B,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1149245,KI,CC(Oc1ccccc1-c1ccccc1)C1=NCCC1
CHEMBL222591,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,8128.31,nM,CHEMBL918089,B,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1149245,KI,CC(Oc1ccccc1-c1ccccc1)C1=NCCO1
CHEMBL1204386,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1513.56,nM,CHEMBL918089,B,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1149245,KI,Cl.c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1
CHEMBL222933,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1230.27,nM,CHEMBL918089,B,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1149245,KI,c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1
CHEMBL374954,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,338.84,nM,CHEMBL918089,B,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1149245,KI,CC(Sc1ccccc1-c1ccccc1)C1=NCCN1
CHEMBL130884,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,91.2,nM,CHEMBL918089,B,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1149245,KI,CC(Nc1ccccc1-c1ccccc1)C1=NCCN1
CHEMBL223836,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,14.79,nM,CHEMBL918089,B,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1149245,KI,CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1
CHEMBL222371,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,37.15,nM,CHEMBL918089,B,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1149245,KI,CC(Oc1ccccc1-c1cccc(N)c1)C1=NCCN1
CHEMBL221523,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,123.03,nM,CHEMBL918089,B,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1149245,KI,CC(Oc1ccccc1-c1ccc([N+](=O)[O-])cc1)C1=NCCN1
CHEMBL222928,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,60.26,nM,CHEMBL918089,B,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1149245,KI,CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1
CHEMBL222138,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,173.78,nM,CHEMBL918089,B,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1149245,KI,CC(Oc1ccccc1-c1ccccc1[N+](=O)[O-])C1=NCCN1
CHEMBL222798,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,33.88,nM,CHEMBL918089,B,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1149245,KI,CC(Oc1ccccc1-c1ccc(O)cc1)C1=NCCN1
CHEMBL374584,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,27.54,nM,CHEMBL918089,B,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1149245,KI,CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1
CHEMBL373830,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,309.03,nM,CHEMBL918089,B,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1149245,KI,CC(Oc1ccccc1-c1ccccc1O)C1=NCCN1
CHEMBL426900,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,41.69,nM,CHEMBL918089,B,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1149245,KI,Cc1ccc(-c2ccccc2OC(C)C2=NCCN2)cc1
CHEMBL222973,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,51.29,nM,CHEMBL918089,B,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1149245,KI,Cc1cccc(-c2ccccc2OC(C)C2=NCCN2)c1
CHEMBL223830,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,46.77,nM,CHEMBL918089,B,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1149245,KI,Cc1ccccc1-c1ccccc1OC(C)C1=NCCN1
CHEMBL385310,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,45.71,nM,CHEMBL918089,B,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1149245,KI,CC(Oc1ccccc1-c1ccsc1)C1=NCCN1
CHEMBL223829,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,16.98,nM,CHEMBL918089,B,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1149245,KI,CC(Oc1ccccc1-c1cccs1)C1=NCCN1
CHEMBL442045,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,281.84,nM,CHEMBL918089,B,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1149245,KI,CC(Oc1ccccc1-c1ccncc1)C1=NCCN1
CHEMBL373535,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,138.04,nM,CHEMBL918089,B,Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1149245,KI,CC(Oc1ccccc1-c1cccnc1)C1=NCCN1
CHEMBL390718,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2.4,nM,CHEMBL905522,B,Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells,CHEMBL1143045,KI,COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2
CHEMBL318235,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,28.0,nM,CHEMBL905522,B,Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells,CHEMBL1143045,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2
CHEMBL318235,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3.1,nM,CHEMBL905522,B,Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells,CHEMBL1143045,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2
CHEMBL318235,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3.4,nM,CHEMBL905522,B,Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells,CHEMBL1143045,KI,COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2
CHEMBL226636,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,117.0,nM,CHEMBL905522,B,Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells,CHEMBL1143045,KI,COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2
CHEMBL226636,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,54.0,nM,CHEMBL905522,B,Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells,CHEMBL1143045,KI,COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2
CHEMBL226636,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,9.0,nM,CHEMBL905522,B,Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells,CHEMBL1143045,KI,COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2
CHEMBL390718,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,87.0,nM,CHEMBL905522,B,Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells,CHEMBL1143045,KI,COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2
CHEMBL390718,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.3,nM,CHEMBL905522,B,Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells,CHEMBL1143045,KI,COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2
CHEMBL128168,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,47.86,nM,CHEMBL895077,B,Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1148710,KI,CC(Oc1ccccc1-c1ccccc1)C1=NCCN1
CHEMBL397753,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,72.44,nM,CHEMBL895077,B,Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1148710,KI,C[C@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1
CHEMBL242693,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,81.28,nM,CHEMBL895077,B,Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1148710,KI,C[C@@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1
CHEMBL222928,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,60.26,nM,CHEMBL895077,B,Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1148710,KI,CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1
CHEMBL223836,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,14.79,nM,CHEMBL895077,B,Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1148710,KI,CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1
CHEMBL374584,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,27.54,nM,CHEMBL895077,B,Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1148710,KI,CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1
CHEMBL373535,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,138.04,nM,CHEMBL895077,B,Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1148710,KI,CC(Oc1ccccc1-c1cccnc1)C1=NCCN1
CHEMBL396013,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,91.2,nM,CHEMBL895077,B,Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1148710,KI,C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1
CHEMBL242265,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,186.21,nM,CHEMBL895077,B,Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1148710,KI,C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1
CHEMBL10316,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,8.0,nM,CHEMBL903398,B,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,CHEMBL1139117,KI,c1ccc2c(c1)OCC(C1=NCCN1)O2
CHEMBL247665,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,186.0,nM,CHEMBL903398,B,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,CHEMBL1139117,KI,COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)N4CCC(N5CCCC5)CC4)cc13)CC2
CHEMBL394218,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,42.0,nM,CHEMBL903398,B,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,CHEMBL1139117,KI,COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NC4CN5CCC4CC5)cc13)CC2
CHEMBL247664,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,141.0,nM,CHEMBL903398,B,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,CHEMBL1139117,KI,COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCC(C)(C)N)cc13)CC2
CHEMBL428407,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,454.0,nM,CHEMBL903398,B,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,CHEMBL1139117,KI,COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCCN(C)C)cc13)CC2
CHEMBL392771,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,216.0,nM,CHEMBL903398,B,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,CHEMBL1139117,KI,COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4cccc(C(=O)NCCN(C)C)c4)cc13)CC2
CHEMBL246852,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,304.0,nM,CHEMBL903398,B,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,CHEMBL1139117,KI,COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4C(F)(F)F)cc13)CC2
CHEMBL393597,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,857.0,nM,CHEMBL903398,B,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,CHEMBL1139117,KI,COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4F)cc13)CC2
CHEMBL246639,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2552.0,nM,CHEMBL903398,B,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,CHEMBL1139117,KI,COc1cccc(-c2cc3c(CN4CCc5cc(OC)c(OC)cc5C4)ccc(OC)c3o2)c1
CHEMBL392992,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1742.0,nM,CHEMBL903398,B,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,CHEMBL1139117,KI,COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4)cc13)CC2
CHEMBL246229,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,135.0,nM,CHEMBL903398,B,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,CHEMBL1139117,KI,COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccn4)cc13)CC2
CHEMBL392991,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,204.0,nM,CHEMBL903398,B,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,CHEMBL1139117,KI,COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccco4)cc13)CC2
CHEMBL246228,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,400.0,nM,CHEMBL903398,B,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,CHEMBL1139117,KI,COc1cc2c(cc1OC)CN(Cc1cnc(N)n3nc(-c4ccco4)nc13)CC2
CHEMBL537669,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.8,nM,CHEMBL903398,B,Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells,CHEMBL1139117,KI,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O.Cl
CHEMBL191703,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,660.69,nM,CHEMBL973678,B,Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells,CHEMBL1157348,KI,C[C@H]1[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H](N(C)C)CC[C@]5(C)[C@H]4CC[C@]23CN1C
CHEMBL14638,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,42.66,nM,CHEMBL973678,B,Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells,CHEMBL1157348,KI,O=C(c1ccc(OCCCc2c[nH]cn2)cc1)C1CC1
CHEMBL260374,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,125.89,nM,CHEMBL973678,B,Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells,CHEMBL1157348,KI,S=C(NC1CCCCC1)N1CCC(c2cnc[nH]2)CC1
CHEMBL1627,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.0,nM,CHEMBL1025630,B,Displacement of [125I]HEAT from adrenergic alpha2A receptor,CHEMBL1140103,KI,CNC(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1
CHEMBL493091,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,69.0,nM,CHEMBL985484,B,Displacement of [3H]MK912 from human cloned adrenergic alpha-2a receptor,CHEMBL1140141,KI,CN(C)CCCOc1ccc(CCNC(=O)c2cc(Br)c[nH]2)cc1Br
CHEMBL494678,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,74.0,nM,CHEMBL1023792,B,Binding affinity to adrenergic alpha2A receptor,CHEMBL1140148,KI,CN1CCN(c2cc(-c3ccc(C#N)cc3)nc(N)n2)CC1
CHEMBL516088,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,863.0,nM,CHEMBL961052,B,Inhibition of human cloned alpha2A adrenergic receptor by competitive binding experiment,CHEMBL1153452,KI,COc1c(OCCF)cccc1C(=O)C1CCN(CCc2ccc(F)cc2)CC1
CHEMBL597,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.7,nM,CHEMBL1013915,B,Displacement of [3H]RX781094 from alpha2 adrenergic receptor,CHEMBL1147348,KI,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1
CHEMBL273485,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,26.92,nM,CHEMBL1015736,B,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1155080,KI,CC(Oc1ccccc1)C1=NCCN1
CHEMBL492648,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,125.89,nM,CHEMBL1015736,B,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1155080,KI,COC1(C2=NCCN2)COc2cccc(-c3ccccc3)c2O1
CHEMBL492647,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,257.04,nM,CHEMBL1015736,B,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1155080,KI,COC1(C2=NCCN2)COc2c(cccc2-c2ccccc2)O1
CHEMBL522151,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,239.88,nM,CHEMBL1015736,B,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1155080,KI,c1ccc(-c2cccc3c2OC(C2=NCCN2)CO3)cc1
CHEMBL492445,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,398.11,nM,CHEMBL1015736,B,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1155080,KI,c1ccc(-c2ccc3c(c2)OC(C2=NCCN2)CO3)cc1
CHEMBL492444,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,281.84,nM,CHEMBL1015736,B,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1155080,KI,c1ccc(-c2ccc3c(c2)OCC(C2=NCCN2)O3)cc1
CHEMBL493272,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,724.44,nM,CHEMBL1015736,B,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1155080,KI,c1ccc(-c2cccc3c2OCC(C2=NCCN2)O3)cc1
CHEMBL523048,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,239.88,nM,CHEMBL1015736,B,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1155080,KI,c1ccc(-c2ccccc2OC(C2=NCCN2)c2ccccc2)cc1
CHEMBL451229,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,74.13,nM,CHEMBL1015736,B,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1155080,KI,CC(Oc1ccccc1C1CCCCC1)C1=NCCN1
CHEMBL495096,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,50.12,nM,CHEMBL1015736,B,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1155080,KI,CC(Oc1ccccc1C1CCCC1)C1=NCCN1
CHEMBL495095,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,57.54,nM,CHEMBL1015736,B,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1155080,KI,C=CCc1ccccc1OC(C)C1=NCCN1
CHEMBL495097,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,213.8,nM,CHEMBL1015736,B,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1155080,KI,CC(Oc1ccccc1/C=N/OCc1ccccc1)C1=NCCN1
CHEMBL492639,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,416.87,nM,CHEMBL1015736,B,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1155080,KI,CCO/N=C/c1ccccc1OC(C)C1=NCCN1
CHEMBL442815,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,660.69,nM,CHEMBL1015736,B,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1155080,KI,CO/N=C/c1ccccc1OC(C)C1=NCCN1
CHEMBL493675,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,288.4,nM,CHEMBL1015736,B,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1155080,KI,CC(Oc1ccccc1/C=N/O)C1=NCCN1
CHEMBL128168,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,47.86,nM,CHEMBL1015736,B,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1155080,KI,CC(Oc1ccccc1-c1ccccc1)C1=NCCN1
CHEMBL10332,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.3631,nM,CHEMBL1015736,B,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1155080,KI,COC1(C2=NCCN2)COc2ccccc2O1
CHEMBL10316,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,7.079,nM,CHEMBL1015736,B,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1155080,KI,c1ccc2c(c1)OCC(C1=NCCN1)O2
CHEMBL494885,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,93.33,nM,CHEMBL1015736,B,Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells,CHEMBL1155080,KI,c1ccc(OC(C2=NCCN2)c2ccccc2)cc1
CHEMBL518592,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,506.0,nM,CHEMBL983549,B,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,CHEMBL1144238,KI,COc1ccccc1N1CCN(CC2COc3ccccc3O2)CC1
CHEMBL477816,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,220.0,nM,CHEMBL983549,B,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,CHEMBL1144238,KI,O=C(NCCN1CCCN(CC2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1
CHEMBL478026,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,27.0,nM,CHEMBL983549,B,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,CHEMBL1144238,KI,O=C(NCCN1CCN(CC2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1
CHEMBL515331,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,208.0,nM,CHEMBL983549,B,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,CHEMBL1144238,KI,N#Cc1cccc(Oc2ncccc2C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)c1
CHEMBL477608,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,138.0,nM,CHEMBL983549,B,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,CHEMBL1144238,KI,CC(C)(C)Nc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1
CHEMBL514837,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,81.0,nM,CHEMBL983549,B,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,CHEMBL1144238,KI,CCCCOc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1
CHEMBL476569,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,118.0,nM,CHEMBL983549,B,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,CHEMBL1144238,KI,CCCCOc1cccc(C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)n1
CHEMBL476774,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,443.0,nM,CHEMBL983549,B,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,CHEMBL1144238,KI,O=C(NCCN1CCCN(CC2COc3ccccc3O2)CC1)c1cccnc1
CHEMBL491419,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,66.1,nM,CHEMBL983549,B,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,CHEMBL1144238,KI,c1ccc(Oc2ncccc2COCCN2CCCN(CC3COc4ccccc4O3)CC2)cc1
CHEMBL491420,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,44.8,nM,CHEMBL983549,B,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,CHEMBL1144238,KI,c1ccc(Oc2ncccc2-c2noc(CN3CCCN(CC4COc5ccccc5O4)CC3)n2)cc1
CHEMBL179648,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,146.1,nM,CHEMBL983549,B,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,CHEMBL1144238,KI,c1ccc(CN2CCN(CC3CCc4ccccc4O3)CC2)cc1
CHEMBL524153,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,94.4,nM,CHEMBL983549,B,Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay,CHEMBL1144238,KI,O=C(NCCN1CCCN(C[C@H]2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1
CHEMBL512062,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,213.0,nM,CHEMBL970453,B,Inhibition of adrenergic alpha2A receptor,CHEMBL1136911,KI,c1ccc(-c2ccccc2[C@@H]2Cc3nccn3C2)cc1
CHEMBL448802,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,805.0,nM,CHEMBL970453,B,Inhibition of adrenergic alpha2A receptor,CHEMBL1136911,KI,c1ccc([C@@H]2Cc3nccn3C2)c(-c2ncco2)c1
CHEMBL448147,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1020.0,nM,CHEMBL970453,B,Inhibition of adrenergic alpha2A receptor,CHEMBL1136911,KI,c1ccc([C@H]2Cc3nccn3C2)c(-c2ncco2)c1
CHEMBL468710,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1750.0,nM,CHEMBL970453,B,Inhibition of adrenergic alpha2A receptor,CHEMBL1136911,KI,c1ccc([C@@H]2Cc3nccn3C2)c(-c2nccs2)c1
CHEMBL468711,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,991.0,nM,CHEMBL970453,B,Inhibition of adrenergic alpha2A receptor,CHEMBL1136911,KI,c1cncc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1
CHEMBL512289,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,112.0,nM,CHEMBL970453,B,Inhibition of adrenergic alpha2A receptor,CHEMBL1136911,KI,c1ccc([C@@H]2Cc3nccn3C2)c(-c2ccncc2)c1
CHEMBL508084,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,380.0,nM,CHEMBL970453,B,Inhibition of adrenergic alpha2A receptor,CHEMBL1136911,KI,Cn1cc(-c2ccccc2[C@@H]2Cc3nccn3C2)cn1
CHEMBL448908,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1100.0,nM,CHEMBL970453,B,Inhibition of adrenergic alpha2A receptor,CHEMBL1136911,KI,c1ccc(-n2cccn2)c([C@@H]2Cc3nccn3C2)c1
CHEMBL513871,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,114.0,nM,CHEMBL970453,B,Inhibition of adrenergic alpha2A receptor,CHEMBL1136911,KI,CS(=O)(=O)Nc1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1
CHEMBL469127,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,280.0,nM,CHEMBL970453,B,Inhibition of adrenergic alpha2A receptor,CHEMBL1136911,KI,CNS(=O)(=O)CCc1ccccc1[C@@H]1Cc2nccn2C1
CHEMBL466012,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,202.0,nM,CHEMBL970453,B,Inhibition of adrenergic alpha2A receptor,CHEMBL1136911,KI,CNC(=O)c1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1
CHEMBL466634,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,469.0,nM,CHEMBL970453,B,Inhibition of adrenergic alpha2A receptor,CHEMBL1136911,KI,Fc1ccc(-c2ncco2)c(C2Cc3nccn3C2)c1
CHEMBL511211,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1470.0,nM,CHEMBL970453,B,Inhibition of adrenergic alpha2A receptor,CHEMBL1136911,KI,Fc1ccc(C2Cc3nccn3C2)c(-c2ccn[nH]2)c1
CHEMBL571314,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,26.92,nM,CHEMBL1047080,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting,CHEMBL1156735,KI,CC(OC1=NCCN1)c1ccccc1
CHEMBL570973,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,57.54,nM,CHEMBL1047080,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting,CHEMBL1156735,KI,C=CCc1ccccc1C(C)OC1=NCCN1
CHEMBL570863,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,24.55,nM,CHEMBL1047080,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting,CHEMBL1156735,KI,Cc1ccccc1C(C)OC1=NCCN1
CHEMBL576078,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,50.12,nM,CHEMBL1047080,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting,CHEMBL1156735,KI,CCCc1ccccc1C(C)OC1=NCCN1
CHEMBL576623,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,22.91,nM,CHEMBL1047080,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting,CHEMBL1156735,KI,CC(OC1=NCCN1)c1ccccc1C1CC1
CHEMBL13852,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,58.88,nM,CHEMBL1047080,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting,CHEMBL1156735,KI,c1ccc(C2CC2)c(OCC2=NCCN2)c1
CHEMBL576819,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,34.67,nM,CHEMBL1047080,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting,CHEMBL1156735,KI,Cc1ccccc1COC1=NCCN1
CHEMBL569933,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,48.98,nM,CHEMBL1047080,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting,CHEMBL1156735,KI,CCCc1ccccc1COC1=NCCN1
CHEMBL467094,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1288.0,nM,CHEMBL1066736,B,Displacement of [3H]Clonidine from human adrenergic alpha2A receptor,CHEMBL1153197,KI,COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2)OCO4
CHEMBL589390,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,109.65,nM,CHEMBL1048659,B,Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells,CHEMBL1153163,KI,Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1
CHEMBL605081,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.8128,nM,CHEMBL1048659,B,Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells,CHEMBL1153163,KI,Cc1ccc(CCn2c3c(c4cc(C)ccc42)CN(C)CC3)cc1
CHEMBL592752,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.995,nM,CHEMBL1048659,B,Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells,CHEMBL1153163,KI,Cc1ccc2c(c1)c1c(n2CCc2ccccc2)CCN(C)C1
CHEMBL605405,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.2399,nM,CHEMBL1048659,B,Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells,CHEMBL1153163,KI,Cc1ccc2c(c1)c1c(n2/C=C\c2ccccc2)CCN(C)C1
CHEMBL226335,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,9340.0,nM,CHEMBL1120977,B,Binding affinity to adrenergic alpha2A receptor,CHEMBL1157752,KI,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O
CHEMBL1085510,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.6,nM,CHEMBL1119141,B,Displacement of [3H]rauwolscine from adrenergic alpha2A receptor,CHEMBL1158639,KI,CN1CC2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21
CHEMBL1224527,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3500.0,nM,CHEMBL1225584,B,Binding affinity to adrenergic alpha2A receptor,CHEMBL1221364,KI,Oc1ccc2c(c1O)C[C@@H](c1ccccc1)[C@@H]1CCNC[C@@H]21
CHEMBL1221498,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.69,nM,CHEMBL1227761,B,Displacement of [3H]MK912 from human alpha2A receptor after 60 mins,CHEMBL1221249,KI,COc1ccccc1N1CCN(CCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL1221499,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,5.19,nM,CHEMBL1227761,B,Displacement of [3H]MK912 from human alpha2A receptor after 60 mins,CHEMBL1221249,KI,COc1ccccc1N1CCN(CCNS(=O)(=O)c2ccc3ccccc3c2)CC1
CHEMBL1221544,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4.59,nM,CHEMBL1227761,B,Displacement of [3H]MK912 from human alpha2A receptor after 60 mins,CHEMBL1221249,KI,COc1ccccc1N1CCN(CCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL497749,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4.64,nM,CHEMBL1227761,B,Displacement of [3H]MK912 from human alpha2A receptor after 60 mins,CHEMBL1221249,KI,COc1ccccc1N1CCN(CCCNS(=O)(=O)c2ccc3ccccc3c2)CC1
CHEMBL25236,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2.75,nM,CHEMBL1227761,B,Displacement of [3H]MK912 from human alpha2A receptor after 60 mins,CHEMBL1221249,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL1221545,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4.1,nM,CHEMBL1227761,B,Displacement of [3H]MK912 from human alpha2A receptor after 60 mins,CHEMBL1221249,KI,COc1ccccc1N1CCN(CCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1
CHEMBL1221591,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,11.1,nM,CHEMBL1227761,B,Displacement of [3H]MK912 from human alpha2A receptor after 60 mins,CHEMBL1221249,KI,COc1ccccc1N1CCN(CCCCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL1221592,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,8.53,nM,CHEMBL1227761,B,Displacement of [3H]MK912 from human alpha2A receptor after 60 mins,CHEMBL1221249,KI,COc1ccccc1N1CCN(CCCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1
CHEMBL1221593,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,6.15,nM,CHEMBL1227761,B,Displacement of [3H]MK912 from human alpha2A receptor after 60 mins,CHEMBL1221249,KI,COc1ccccc1N1CCN(CCCCCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL1221594,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2.87,nM,CHEMBL1227761,B,Displacement of [3H]MK912 from human alpha2A receptor after 60 mins,CHEMBL1221249,KI,COc1ccccc1N1CCN(CCCCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1
CHEMBL1242950,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,530.0,nM,CHEMBL1248559,B,Binding affinity to human adrenergic alpha2A receptor by radioligand displacement assay,CHEMBL1240489,KI,CCCCC1CCN(CCCC(=O)c2ccccc2C)CC1
CHEMBL1255771,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.4467,nM,CHEMBL1259385,B,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CHEMBL1255566,KI,C[C@]12C[C@@]1(c1c[nH]cn1)Cc1ccccc12
CHEMBL1255770,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.072,nM,CHEMBL1259385,B,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CHEMBL1255566,KI,CC1(C)[C@@H]2c3ccccc3C[C@@]21c1c[nH]cn1
CHEMBL1255724,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.4074,nM,CHEMBL1259385,B,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CHEMBL1255566,KI,CCC[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1
CHEMBL1255723,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.138,nM,CHEMBL1259385,B,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CHEMBL1255566,KI,CC[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1
CHEMBL1256378,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.1738,nM,CHEMBL1259385,B,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CHEMBL1255566,KI,C[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1
CHEMBL1255617,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3.89,nM,CHEMBL1259385,B,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CHEMBL1255566,KI,c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1
CHEMBL1255617,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.3311,nM,CHEMBL1259385,B,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CHEMBL1255566,KI,c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1
CHEMBL1255617,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.6026,nM,CHEMBL1259385,B,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CHEMBL1255566,KI,c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1
CHEMBL1255616,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.8511,nM,CHEMBL1259385,B,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CHEMBL1255566,KI,CCC[C@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1
CHEMBL1256610,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.5129,nM,CHEMBL1259385,B,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CHEMBL1255566,KI,CC[C@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1
CHEMBL1256609,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.2188,nM,CHEMBL1259385,B,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CHEMBL1255566,KI,C[C@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1
CHEMBL1256608,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,45.71,nM,CHEMBL1259385,B,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CHEMBL1255566,KI,CC(C)O[C@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1
CHEMBL1256566,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3.981,nM,CHEMBL1259385,B,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CHEMBL1255566,KI,CCCO[C@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1
CHEMBL1256565,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3.311,nM,CHEMBL1259385,B,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CHEMBL1255566,KI,CCO[C@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1
CHEMBL1256503,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,54.95,nM,CHEMBL1259385,B,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CHEMBL1255566,KI,CO[C@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1
CHEMBL1256503,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.5623,nM,CHEMBL1259385,B,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CHEMBL1255566,KI,CO[C@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1
CHEMBL1256503,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.738,nM,CHEMBL1259385,B,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CHEMBL1255566,KI,CO[C@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1
CHEMBL1256502,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,11.75,nM,CHEMBL1259385,B,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CHEMBL1255566,KI,CO[C@@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1
CHEMBL1256414,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.02818,nM,CHEMBL1259385,B,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CHEMBL1255566,KI,c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21
CHEMBL1256414,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.07943,nM,CHEMBL1259385,B,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CHEMBL1255566,KI,c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21
CHEMBL1256414,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.06918,nM,CHEMBL1259385,B,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CHEMBL1255566,KI,c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21
CHEMBL1255582,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,7.244,nM,CHEMBL1259385,B,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CHEMBL1255566,KI,CCC1(c2c[nH]cn2)Cc2ccc(F)cc2C1
CHEMBL353972,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.862,nM,CHEMBL1259385,B,Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting,CHEMBL1255566,KI,CCC1(c2c[nH]cn2)Cc2ccccc2C1
CHEMBL1258223,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2239.0,nM,CHEMBL1259771,B,Binding affinity to human adrenergic alpha2A receptor,CHEMBL1255169,KI,CCCCN1CCC(COC(=O)c2cc(Cl)c(NC)c3c2OCCO3)CC1
CHEMBL273485,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,26.92,nM,CHEMBL1285950,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CHEMBL1275329,KI,CC(Oc1ccccc1)C1=NCCN1
CHEMBL128168,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,47.86,nM,CHEMBL1285950,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CHEMBL1275329,KI,CC(Oc1ccccc1-c1ccccc1)C1=NCCN1
CHEMBL242265,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,186.21,nM,CHEMBL1285950,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CHEMBL1275329,KI,C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1
CHEMBL396013,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,91.2,nM,CHEMBL1285950,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CHEMBL1275329,KI,C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1
CHEMBL222928,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,60.26,nM,CHEMBL1285950,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CHEMBL1275329,KI,CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1
CHEMBL242693,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,81.28,nM,CHEMBL1285950,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CHEMBL1275329,KI,C[C@@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1
CHEMBL397753,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,72.44,nM,CHEMBL1285950,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CHEMBL1275329,KI,C[C@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1
CHEMBL495095,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,57.54,nM,CHEMBL1285950,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CHEMBL1275329,KI,C=CCc1ccccc1OC(C)C1=NCCN1
CHEMBL1276139,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,100.0,nM,CHEMBL1285950,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CHEMBL1275329,KI,C=CCc1ccccc1O[C@H](C)C1=NCCN1
CHEMBL1276140,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,52.48,nM,CHEMBL1285950,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CHEMBL1275329,KI,C=CCc1ccccc1O[C@@H](C)C1=NCCN1
CHEMBL1276218,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,22.91,nM,CHEMBL1285950,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CHEMBL1275329,KI,CC(Oc1ccccc1C1CC1)C1=NCCN1
CHEMBL1276219,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,44.67,nM,CHEMBL1285950,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CHEMBL1275329,KI,C[C@@H](Oc1ccccc1C1CC1)C1=NCCN1
CHEMBL1276220,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,20.89,nM,CHEMBL1285950,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CHEMBL1275329,KI,C[C@H](Oc1ccccc1C1CC1)C1=NCCN1
CHEMBL385310,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,45.71,nM,CHEMBL1285950,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CHEMBL1275329,KI,CC(Oc1ccccc1-c1ccsc1)C1=NCCN1
CHEMBL1276247,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,165.96,nM,CHEMBL1285950,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CHEMBL1275329,KI,C[C@@H](Oc1ccccc1-c1ccsc1)C1=NCCN1
CHEMBL1276248,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,44.67,nM,CHEMBL1285950,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CHEMBL1275329,KI,C[C@H](Oc1ccccc1-c1ccsc1)C1=NCCN1
CHEMBL374584,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,27.54,nM,CHEMBL1285950,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CHEMBL1275329,KI,CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1
CHEMBL1278084,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,39.81,nM,CHEMBL1285950,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CHEMBL1275329,KI,C[C@@H](Oc1ccccc1-c1cccc(O)c1)C1=NCCN1
CHEMBL1278085,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,97.72,nM,CHEMBL1285950,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells,CHEMBL1275329,KI,C[C@H](Oc1ccccc1-c1cccc(O)c1)C1=NCCN1
CHEMBL1643900,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,7609.0,nM,CHEMBL1646413,B,Inhibition of alpha2A adrenergic receptor,CHEMBL1641373,KI,Fc1cccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)c1
CHEMBL221753,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1163.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1.[Cl-]
CHEMBL493,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,5.533,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
CHEMBL990,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1366.6,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12
CHEMBL1366,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,331.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,
CHEMBL508112,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,337.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,c1ccc2sc(SSc3nc4ccccc4s3)nc2c1
CHEMBL290106,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1434.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O
CHEMBL1201203,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,204.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN1[C@@H]2CC[C@H]1C[C@@H](OC(c1ccccc1)c1ccccc1)C2
CHEMBL1476898,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1709.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,
CHEMBL296419,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1817.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1
CHEMBL844,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,112.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,Brc1c(NC2=NCCN2)ccc2nccnc12
CHEMBL1458880,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2594.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,
CHEMBL1113,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,493.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2
CHEMBL1381098,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2352.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,S=C=Nc1cccc2ccccc12
CHEMBL153062,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2543.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CCCCCCCCCc1ccc(O)cc1
CHEMBL195437,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,5358.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CCCCCCCCc1ccc(O)cc1
CHEMBL633,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,117.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1
CHEMBL1403281,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2.98,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
CHEMBL1365675,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,347.6,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1
CHEMBL629,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,132.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN(C)CCC=C1c2ccccc2CCc2ccccc21
CHEMBL311469,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,7898.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2
CHEMBL1491,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,226.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl
CHEMBL1289,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,458.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,Clc1cc(Cl)c(OCC#CI)cc1Cl
CHEMBL305660,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,311.9,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1
CHEMBL64894,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,201.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]
CHEMBL808,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1622.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1
CHEMBL679,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,276.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CNC[C@H](O)c1ccc(O)c(O)c1
CHEMBL420,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,15.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,N=C(N)N/N=C/c1c(Cl)cccc1Cl
CHEMBL496,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2061.2,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl
CHEMBL50588,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,14.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21
CHEMBL862,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,50.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl
CHEMBL1385840,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2.361,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
CHEMBL30008,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,218.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1
CHEMBL119443,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,630.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL726,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,80.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1
CHEMBL442,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.796,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL1108,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1112.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
CHEMBL54,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1865.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL134,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,105.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,Clc1cccc(Cl)c1NC1=NCCN1
CHEMBL7002,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,6207.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1
CHEMBL1729,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,666.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC
CHEMBL1628227,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,501.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN(C)CCC=C1c2ccccc2COc2ccccc21
CHEMBL648,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,582.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN1CCN(C(c2ccccc2)c2ccccc2)CC1
CHEMBL1255837,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.747,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O
CHEMBL1732,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.387,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL964,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1839.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CCN(CC)C(=S)SSC(=S)N(CC)CC
CHEMBL104,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4457.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1
CHEMBL411,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,5297.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1
CHEMBL954,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,351.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1
CHEMBL42,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,34.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL1200406,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1617.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O
CHEMBL71,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,132.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21
CHEMBL43064,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,167.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1
CHEMBL219916,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1027.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1
CHEMBL415,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,530.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21
CHEMBL516,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,106.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1
CHEMBL1479,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,6873.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C
CHEMBL1201353,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,7625.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1
CHEMBL723,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,40.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12
CHEMBL334255,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,91.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-]
CHEMBL1626,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,69.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1
CHEMBL762,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,8.639,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1
CHEMBL55,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,516.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1
CHEMBL564,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,126.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN(C)CCCN1c2ccccc2Sc2ccccc21
CHEMBL643,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,256.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CC(CN1c2ccccc2Sc2ccccc21)N(C)C
CHEMBL531,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,99.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL2,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,989.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
CHEMBL511,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1116.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,COc1ccc(CN(CCN(C)C)c2ccccn2)cc1
CHEMBL715,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,203.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL597,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2.25,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1
CHEMBL1909072,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,25.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1
CHEMBL1262,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1531.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1
CHEMBL445,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,275.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CNCCC=C1c2ccccc2CCc2ccccc21
CHEMBL716,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,934.3,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
CHEMBL728,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,63.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1
CHEMBL7568,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,855.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12
CHEMBL900,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,809.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,Cc1ccccc1C(OCCN(C)C)c1ccccc1
CHEMBL21731,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,684.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CNCCCC12CCC(c3ccccc31)c1ccccc12
CHEMBL86,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1020.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC
CHEMBL6437,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,16.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN1CCN2c3ccccc3Cc3ccccc3C2C1
CHEMBL91,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1487.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1
CHEMBL1200633,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2189.9,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O
CHEMBL1221512,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,162.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS
CHEMBL19215,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,22.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21
CHEMBL1909062,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1349.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,
CHEMBL157138,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.116,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL787,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1470.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1
CHEMBL1909065,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,67.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C
CHEMBL1411979,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,437.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN(C)CCN(Cc1cccs1)c1ccccn1
CHEMBL60889,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1379.8,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1
CHEMBL1201356,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,596.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL157101,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,7419.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1
CHEMBL395110,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,546.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1
CHEMBL1670,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2755.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1
CHEMBL1065,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,611.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1
CHEMBL534,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,820.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1
CHEMBL119385,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,12813.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl
CHEMBL621,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,341.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12
CHEMBL6966,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,217.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC
CHEMBL15245,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2.307,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
CHEMBL611,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,5187.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC
CHEMBL479,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,50.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2
CHEMBL972,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,674.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,C#CCN(C)[C@H](C)Cc1ccccc1
CHEMBL1221,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1516.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1
CHEMBL83,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,726.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1
CHEMBL84158,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,779.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC
CHEMBL822,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2138.6,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12
CHEMBL85,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3.628,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL12948,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1803.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CC1CCC(NC(=O)N(CCCl)N=O)CC1
CHEMBL809,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,108.3,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21
CHEMBL404849,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,758.7,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1
CHEMBL833,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,143.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,Clc1ccccc1CN1CCc2sccc2C1
CHEMBL1306,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,369.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1
CHEMBL26,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,757.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC
CHEMBL508338,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,200.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,
CHEMBL81,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,624.0,nM,CHEMBL1909088,B,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),CHEMBL1909046,KI,O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12
CHEMBL1956191,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,28.84,nM,CHEMBL1960286,B,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CHEMBL1955818,KI,CC(Oc1ccccc1Cl)C1=NCCN1
CHEMBL1956192,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,22.91,nM,CHEMBL1960286,B,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CHEMBL1955818,KI,CC(Oc1ccccc1Br)C1=NCCN1
CHEMBL1956193,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,181.97,nM,CHEMBL1960286,B,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CHEMBL1955818,KI,CC(Oc1ccccc1C(F)(F)F)C1=NCCN1
CHEMBL156336,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,23.99,nM,CHEMBL1960286,B,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CHEMBL1955818,KI,CCc1ccccc1OC(C)C1=NCCN1
CHEMBL266613,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,72.44,nM,CHEMBL1960286,B,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CHEMBL1955818,KI,CC(Oc1ccccc1C(C)C)C1=NCCN1
CHEMBL1956194,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,72.44,nM,CHEMBL1960286,B,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CHEMBL1955818,KI,C=C(C)c1ccccc1OC(C)C1=NCCN1
CHEMBL1956195,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,36.31,nM,CHEMBL1960286,B,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CHEMBL1955818,KI,CC(Oc1ccccc1CC1CC1)C1=NCCN1
CHEMBL1956196,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,97.72,nM,CHEMBL1960286,B,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CHEMBL1955818,KI,CCOc1ccccc1OC(C)C1=NCCN1
CHEMBL14208,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,83.18,nM,CHEMBL1960286,B,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CHEMBL1955818,KI,CC(C)Oc1ccccc1OC(C)C1=NCCN1
CHEMBL1956197,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,83.18,nM,CHEMBL1960286,B,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CHEMBL1955818,KI,CC(Oc1ccccc1OC1CC1)C1=NCCN1
CHEMBL1956199,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,57.54,nM,CHEMBL1960286,B,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CHEMBL1955818,KI,COc1ccccc1OC(C)C1=NCCN1
CHEMBL1956200,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3162.28,nM,CHEMBL1960286,B,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CHEMBL1955818,KI,CC(Oc1ccccc1S(C)(=O)=O)C1=NCCN1
CHEMBL1956201,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1047.13,nM,CHEMBL1960286,B,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CHEMBL1955818,KI,CC(Oc1ccccc1C=O)C1=NCCN1
CHEMBL1956202,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1023.29,nM,CHEMBL1960286,B,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CHEMBL1955818,KI,CC(=O)c1ccccc1OC(C)C1=NCCN1
CHEMBL17860,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4.365,nM,CHEMBL1960286,B,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CHEMBL1955818,KI,CC(Oc1c(Cl)cccc1Cl)C1=NCCN1
CHEMBL155866,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,11.75,nM,CHEMBL1960286,B,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CHEMBL1955818,KI,Cc1cccc(C)c1OC(C)C1=NCCN1
CHEMBL157955,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,31.62,nM,CHEMBL1960286,B,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CHEMBL1955818,KI,CCc1cccc(CC)c1OC(C)C1=NCCN1
CHEMBL157206,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,16.6,nM,CHEMBL1960286,B,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CHEMBL1955818,KI,C=CCc1cccc(CC=C)c1OC(C)C1=NCCN1
CHEMBL1956203,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,489.78,nM,CHEMBL1960286,B,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CHEMBL1955818,KI,CC(Oc1c(-c2ccccc2)cccc1-c1ccccc1)C1=NCCN1
CHEMBL10316,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,7.079,nM,CHEMBL1959312,B,Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting,CHEMBL1955779,KI,c1ccc2c(c1)OCC(C1=NCCN1)O2
CHEMBL1956900,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,501.19,nM,CHEMBL1959312,B,Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting,CHEMBL1955779,KI,c1ccc(C2COC(C3=NCCN3)CO2)cc1
CHEMBL1956901,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,7943.28,nM,CHEMBL1959312,B,Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting,CHEMBL1955779,KI,c1ccc([C@H]2CO[C@H](C3=NCCN3)CO2)cc1
CHEMBL1956902,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,398.11,nM,CHEMBL1959312,B,Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting,CHEMBL1955779,KI,c1ccc([C@@H]2CO[C@@H](C3=NCCN3)CO2)cc1
CHEMBL1956903,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,5370.32,nM,CHEMBL1959312,B,Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting,CHEMBL1955779,KI,c1ccc([C@H]2COC[C@@H](C3=NCCN3)O2)cc1
CHEMBL1956904,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,6309.57,nM,CHEMBL1959312,B,Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting,CHEMBL1955779,KI,c1ccc([C@@H]2COC[C@@H](C3=NCCN3)O2)cc1
CHEMBL1956906,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3801.89,nM,CHEMBL1959312,B,Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting,CHEMBL1955779,KI,c1ccc(C2(c3ccccc3)COCC(C3=NCCN3)O2)cc1
CHEMBL2022269,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,729.0,nM,CHEMBL2026264,B,Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting,CHEMBL2021876,KI,Clc1ccc2c(c1)N=C(N1CCNCC1)c1cccnc1O2
CHEMBL2022272,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,374.0,nM,CHEMBL2026264,B,Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting,CHEMBL2021876,KI,Clc1ccc2c(c1)N=C(N1CCN(CCc3ccccc3)CC1)c1cccnc1O2
CHEMBL2022273,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,412.0,nM,CHEMBL2026264,B,Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting,CHEMBL2021876,KI,Clc1ccc2c(c1)N=C(N1CCN(C3CCCCC3)CC1)c1cccnc1O2
CHEMBL2022275,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,452.0,nM,CHEMBL2026264,B,Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting,CHEMBL2021876,KI,OCCOCCN1CCN(C2=Nc3cc(Cl)ccc3Oc3ncccc32)CC1
CHEMBL2022280,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,180.0,nM,CHEMBL2026264,B,Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting,CHEMBL2021876,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Oc3ncccc32)CC1.O=C(O)/C=C/C(=O)O
CHEMBL42,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,185.0,nM,CHEMBL2026264,B,Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting,CHEMBL2021876,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL134,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,8.71,nM,CHEMBL2060407,B,Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter,CHEMBL2057159,KI,Clc1cccc(Cl)c1NC1=NCCN1
CHEMBL2058631,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1949.84,nM,CHEMBL2060407,B,Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter,CHEMBL2057159,KI,CC1CNC(Nc2c(Cl)cccc2Cl)=N1
CHEMBL289480,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,36.31,nM,CHEMBL2060407,B,Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter,CHEMBL2057159,KI,C1COC(NC(C2CC2)C2CC2)=N1
CHEMBL2058632,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4897.79,nM,CHEMBL2060407,B,Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter,CHEMBL2057159,KI,CC1COC(NC(C2CC2)C2CC2)=N1
CHEMBL2058633,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3019.95,nM,CHEMBL2060407,B,Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter,CHEMBL2057159,KI,Clc1ccccc1NC1=NCCC1
CHEMBL2058635,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2570.4,nM,CHEMBL2060407,B,Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter,CHEMBL2057159,KI,CC1CCC(Nc2ccc(I)cc2Cl)=N1
CHEMBL495095,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,57.54,nM,CHEMBL2090847,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting,CHEMBL2086372,KI,C=CCc1ccccc1OC(C)C1=NCCN1
CHEMBL1276139,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,100.0,nM,CHEMBL2090847,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting,CHEMBL2086372,KI,C=CCc1ccccc1O[C@H](C)C1=NCCN1
CHEMBL1276140,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,52.48,nM,CHEMBL2090847,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting,CHEMBL2086372,KI,C=CCc1ccccc1O[C@@H](C)C1=NCCN1
CHEMBL1956195,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,36.31,nM,CHEMBL2090847,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting,CHEMBL2086372,KI,CC(Oc1ccccc1CC1CC1)C1=NCCN1
CHEMBL2089155,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,44.67,nM,CHEMBL2090847,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting,CHEMBL2086372,KI,C[C@@H](Oc1ccccc1CC1CC1)C1=NCCN1
CHEMBL2089156,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,41.69,nM,CHEMBL2090847,B,Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting,CHEMBL2086372,KI,C[C@H](Oc1ccccc1CC1CC1)C1=NCCN1
CHEMBL2205361,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1232.0,nM,CHEMBL2209487,B,Displacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysis,CHEMBL2203183,KI,Cc1c(C(=O)N(CCCN2CCCCC2)c2ccccc2)oc2ccccc12
CHEMBL2205362,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,945.0,nM,CHEMBL2209487,B,Displacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysis,CHEMBL2203183,KI,COc1cc2oc(C(=O)N(CCCN3CCCCC3)c3ccccc3)c(C)c2cc1OC
CHEMBL2205360,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,653.0,nM,CHEMBL2209487,B,Displacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysis,CHEMBL2203183,KI,COc1ccc2c(C)c(C(=O)N(CCCN3CCCCC3)c3ccccc3)oc2c1
CHEMBL2207493,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,17170.0,nM,CHEMBL2213175,B,Displacement of [3H]UK 14.304 from human adrenergic alpha2A receptor,CHEMBL2203152,KI,CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1
CHEMBL2205836,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1301.0,nM,CHEMBL2210365,B,Binding affinity to alpha2A adrenergic receptor,CHEMBL2203059,KI,COc1ccccc1CCN1C2C3C4CC5C6C4C2C6C1(O)C53
CHEMBL326702,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,169.82,nM,CHEMBL3057218,B,Binding affinity to Homo sapiens (human) alpha2A receptor,CHEMBL3046380,KI,CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1
CHEMBL2261346,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,33.11,nM,CHEMBL3057218,B,Binding affinity to Homo sapiens (human) alpha2A receptor,CHEMBL3046380,KI,Br.CS(=O)(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1
CHEMBL30713,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,635.0,nM,CHEMBL2395838,B,Displacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysis,CHEMBL2390840,KI,CC(N)Cc1c[nH]c2ccccc12
CHEMBL30713,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,630.96,nM,CHEMBL2395838,B,Displacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysis,CHEMBL2390840,KI,CC(N)Cc1c[nH]c2ccccc12
CHEMBL15245,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3.1,nM,CHEMBL2395285,B,Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins,CHEMBL2390918,KI,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
CHEMBL481153,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,95.0,nM,CHEMBL2404423,B,Antagonist activity at adrenergic alpha2A receptor (unknown origin) by PDSP assay,CHEMBL2401658,KI,O=C(OCCN1CCCC1)N1c2ccccc2Sc2ccccc21
CHEMBL2413154,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,96.0,nM,CHEMBL2416741,B,Binding affinity to adrenergic alpha2A receptor (unknown origin),CHEMBL2413016,KI,COc1ccccc1N1CCN(CCCCn2ncc(=O)n(C)c2=O)CC1
CHEMBL2413153,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2751.0,nM,CHEMBL2416741,B,Binding affinity to adrenergic alpha2A receptor (unknown origin),CHEMBL2413016,KI,Cn1c(=O)cnn(CCCCN2CCN(c3ccccc3OCCF)CC2)c1=O
CHEMBL404505,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,26915.35,nM,CHEMBL2434577,B,Binding affinity at human alpha2A AR,CHEMBL2429812,KI,c1ccc2oc(C3=NCCN3)cc2c1
CHEMBL2431280,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,316.23,nM,CHEMBL2434577,B,Binding affinity at human alpha2A AR,CHEMBL2429812,KI,c1ccc(OC2CC2)c(OCC2=NCCN2)c1
CHEMBL2431279,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,95.5,nM,CHEMBL2434577,B,Binding affinity at human alpha2A AR,CHEMBL2429812,KI,Brc1ccccc1OCC1=NCCN1
CHEMBL13917,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,48.98,nM,CHEMBL2434577,B,Binding affinity at human alpha2A AR,CHEMBL2429812,KI,CCCc1ccccc1OCC1=NCCN1
CHEMBL13852,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,58.88,nM,CHEMBL2434577,B,Binding affinity at human alpha2A AR,CHEMBL2429812,KI,c1ccc(C2CC2)c(OCC2=NCCN2)c1
CHEMBL2431281,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,77.62,nM,CHEMBL2434577,B,Binding affinity at human alpha2A AR,CHEMBL2429812,KI,c1ccc(OCC2=NCCN2)c(CC2CC2)c1
CHEMBL14107,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,125.89,nM,CHEMBL2434577,B,Binding affinity at human alpha2A AR,CHEMBL2429812,KI,C=CCc1ccccc1OCC1=NCCN1
CHEMBL1956197,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,83.18,nM,CHEMBL2434577,B,Binding affinity at human alpha2A AR,CHEMBL2429812,KI,CC(Oc1ccccc1OC1CC1)C1=NCCN1
CHEMBL1956192,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,22.91,nM,CHEMBL2434577,B,Binding affinity at human alpha2A AR,CHEMBL2429812,KI,CC(Oc1ccccc1Br)C1=NCCN1
CHEMBL2431282,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,50.12,nM,CHEMBL2434577,B,Binding affinity at human alpha2A AR,CHEMBL2429812,KI,CCCc1ccccc1OC(C)C1=NCCN1
CHEMBL1276220,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,20.89,nM,CHEMBL2434577,B,Binding affinity at human alpha2A AR,CHEMBL2429812,KI,C[C@H](Oc1ccccc1C1CC1)C1=NCCN1
CHEMBL1276219,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,44.67,nM,CHEMBL2434577,B,Binding affinity at human alpha2A AR,CHEMBL2429812,KI,C[C@@H](Oc1ccccc1C1CC1)C1=NCCN1
CHEMBL1276218,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,22.91,nM,CHEMBL2434577,B,Binding affinity at human alpha2A AR,CHEMBL2429812,KI,CC(Oc1ccccc1C1CC1)C1=NCCN1
CHEMBL2089156,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,41.69,nM,CHEMBL2434577,B,Binding affinity at human alpha2A AR,CHEMBL2429812,KI,C[C@H](Oc1ccccc1CC1CC1)C1=NCCN1
CHEMBL2089155,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,44.67,nM,CHEMBL2434577,B,Binding affinity at human alpha2A AR,CHEMBL2429812,KI,C[C@@H](Oc1ccccc1CC1CC1)C1=NCCN1
CHEMBL1956195,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,36.31,nM,CHEMBL2434577,B,Binding affinity at human alpha2A AR,CHEMBL2429812,KI,CC(Oc1ccccc1CC1CC1)C1=NCCN1
CHEMBL1276140,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,52.48,nM,CHEMBL2434577,B,Binding affinity at human alpha2A AR,CHEMBL2429812,KI,C=CCc1ccccc1O[C@@H](C)C1=NCCN1
CHEMBL1276139,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,100.0,nM,CHEMBL2434577,B,Binding affinity at human alpha2A AR,CHEMBL2429812,KI,C=CCc1ccccc1O[C@H](C)C1=NCCN1
CHEMBL495095,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,57.54,nM,CHEMBL2434577,B,Binding affinity at human alpha2A AR,CHEMBL2429812,KI,C=CCc1ccccc1OC(C)C1=NCCN1
CHEMBL1643900,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,7609.0,nM,CHEMBL2432459,B,Inhibition of adrenergic alpha2A receptor (unknown origin) by PDSP assay,CHEMBL2429832,KI,Fc1cccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)c1
CHEMBL2432046,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,5211.0,nM,CHEMBL2432459,B,Inhibition of adrenergic alpha2A receptor (unknown origin) by PDSP assay,CHEMBL2429832,KI,COc1ccc(CN[C@H]2C3C4CC5C6C4CC3C6C52)cc1OC
CHEMBL2436555,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,316.23,nM,CHEMBL2439895,B,Displacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysis,CHEMBL2434905,KI,Cl.NC1=Nc2ccc(Cl)cc2CN1
CHEMBL2436555,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,283.0,nM,CHEMBL2439895,B,Displacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysis,CHEMBL2434905,KI,Cl.NC1=Nc2ccc(Cl)cc2CN1
CHEMBL2441619,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1202.0,nM,CHEMBL2445022,B,Binding affinity to alpha2A adrenoceptor receptor (unknown origin),CHEMBL2440021,KI,Cc1ccc2nc(C(F)(F)F)cc(N3CCNCC3)c2c1
CHEMBL762,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2.291,nM,CHEMBL3106122,B,Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin),CHEMBL3102773,KI,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1
CHEMBL762,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.29,nM,CHEMBL3106122,B,Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin),CHEMBL3102773,KI,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1
CHEMBL3104093,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,407.0,nM,CHEMBL3106122,B,Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin),CHEMBL3102773,KI,CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1
CHEMBL3104092,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1800.0,nM,CHEMBL3106122,B,Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin),CHEMBL3102773,KI,CN1CCc2c(c3cccc4c3n2Cc2ccccc2C4)C1
CHEMBL3104091,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,228.0,nM,CHEMBL3106122,B,Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin),CHEMBL3102773,KI,CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1
CHEMBL3104093,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,407.38,nM,CHEMBL3106122,B,Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin),CHEMBL3102773,KI,CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1
CHEMBL3104092,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1819.7,nM,CHEMBL3106122,B,Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin),CHEMBL3102773,KI,CN1CCc2c(c3cccc4c3n2Cc2ccccc2C4)C1
CHEMBL3104091,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,229.09,nM,CHEMBL3106122,B,Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin),CHEMBL3102773,KI,CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1
CHEMBL715,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1000.0,nM,CHEMBL3225629,B,Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay,CHEMBL3217546,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL42,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1000.0,nM,CHEMBL3225629,B,Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay,CHEMBL3217546,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL1112,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,100.0,nM,CHEMBL3225629,B,Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay,CHEMBL3217546,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL85,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1000.0,nM,CHEMBL3225629,B,Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay,CHEMBL3217546,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL3217984,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,63.1,nM,CHEMBL3225629,B,Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay,CHEMBL3217546,KI,CN1CCC2C(C1)c1cccc3c1N2c1ccccc1CS3
CHEMBL1256176,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1.905,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,COC1(C2=NCCN2)COc2ccccc2O1.Cl
CHEMBL1705,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,20.89,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,Cl.Clc1cccc(Cl)c1NC1=NCCN1
CHEMBL3289533,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1479.11,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CCOc1ccc(/N=C(/N)NCc2ccco2)cc1.Cl
CHEMBL3289532,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,213.8,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CN(C)c1ccc(/N=C(/N)NCc2ccco2)cc1.Cl
CHEMBL3289531,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,512.86,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,Cl.N=C(NCc1ccco1)Nc1ccc2c(c1)CCCC2
CHEMBL3289530,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1071.52,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CCNc1ccc(/N=C(/N)NCc2ccco2)cc1.Cl
CHEMBL3289529,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1513.56,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,Cl.N=C(NCc1ccco1)Nc1ccc2c(c1)OCO2
CHEMBL3289528,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,19054.61,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CCOc1ccc(NC(=N)NCCO)cc1.Cl
CHEMBL3289527,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1862.09,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CN(C)c1ccc(NC(=N)NCCO)cc1.Cl
CHEMBL3289526,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1737.8,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,Cl.N=C(NCCO)Nc1ccc2c(c1)CCCC2
CHEMBL3289525,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,18620.87,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CCNc1ccc(NC(=N)NCCO)cc1.Cl
CHEMBL3289524,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,11748.98,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,Cl.N=C(NCCO)Nc1ccc2c(c1)OCO2
CHEMBL3289523,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2238.72,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CCOc1ccc(NC(=N)Nc2ccccc2)cc1.Cl
CHEMBL3289522,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,389.05,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CN(C)c1ccc(NC(=N)Nc2ccccc2)cc1.Cl
CHEMBL3289521,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,263.03,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,Cl.N=C(Nc1ccccc1)Nc1ccc2c(c1)CCCC2
CHEMBL3289520,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4897.79,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CCNc1ccc(NC(=N)Nc2ccccc2)cc1.Cl
CHEMBL3289534,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4365.16,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,Cl.N=C(Nc1ccccc1)Nc1ccc2c(c1)OCO2
CHEMBL3289535,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4265.8,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CCCNC(=N)Nc1ccc(OCC)cc1.Cl
CHEMBL3289536,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1122.02,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CCCNC(=N)Nc1ccc(N(C)C)cc1.Cl
CHEMBL3289537,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,676.08,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CCCNC(=N)Nc1ccc2c(c1)CCCC2.Cl
CHEMBL3289538,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,8317.64,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CCCNC(=N)Nc1ccc(NCC)cc1.Cl
CHEMBL3289539,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,15135.61,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CCCNC(=N)Nc1ccc2c(c1)OCO2.Cl
CHEMBL3289540,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,141.25,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CCOc1ccc(NC(=N)N)cc1.Cl
CHEMBL3289541,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,14125.38,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CCOc1ccc(/N=C2/NCC(C)N2)cc1.Cl
CHEMBL3289542,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3311.31,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CC1CN/C(=N/c2ccc(N(C)C)cc2)N1.Cl
CHEMBL3289543,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1000.0,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CC1CN/C(=N/c2ccc3c(c2)CCCC3)N1.Cl
CHEMBL3289544,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,12302.69,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CCNc1ccc(/N=C2/NCC(C)N2)cc1.Cl
CHEMBL3289545,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2344.23,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CC1CN/C(=N/c2ccc3c(c2)OCO3)N1.Cl
CHEMBL3289546,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2630.27,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CCOc1ccc(/N=C2/NCC(c3ccco3)N2)cc1.Cl
CHEMBL3289547,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1318.26,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CN(C)c1ccc(/N=C2/NCC(c3ccco3)N2)cc1.Cl
CHEMBL3289548,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,691.83,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,Cl.c1coc(C2CN/C(=N/c3ccc4c(c3)CCCC4)N2)c1
CHEMBL3289549,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2187.76,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CCNc1ccc(/N=C2/NCC(c3ccco3)N2)cc1.Cl
CHEMBL3289550,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1698.24,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,Cl.c1coc(C2CN/C(=N/c3ccc4c(c3)OCO4)N2)c1
CHEMBL3289551,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,79.43,nM,CHEMBL3296644,B,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,CHEMBL3286260,KI,CCOc1ccc(N=C2NCCN2)cc1.Cl
CHEMBL3289656,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,844.0,nM,CHEMBL3293216,B,Displacement of [3H]clonidine from human adrenergic-alpha2A receptor by PDSP assay,CHEMBL3286287,KI,c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1
CHEMBL3289656,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,851.14,nM,CHEMBL3293216,B,Displacement of [3H]clonidine from human adrenergic-alpha2A receptor by PDSP assay,CHEMBL3286287,KI,c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1
CHEMBL3104093,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,407.0,nM,CHEMBL3373283,B,Binding affinity to adrenergic alpha 2A receptor (unknown origin),CHEMBL3352436,KI,CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1
CHEMBL1186220,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,52.0,nM,CHEMBL3378316,B,Displacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting,CHEMBL3351639,KI,c1ccc2c(c1)cnn2N=C1NCCN1
CHEMBL3343699,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,33.0,nM,CHEMBL3378316,B,Displacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting,CHEMBL3351639,KI,Fc1ccc2cnn(N=C3NCCN3)c2c1
CHEMBL3343700,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,65.0,nM,CHEMBL3378316,B,Displacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting,CHEMBL3351639,KI,Fc1cccc2cnn(N=C3NCCN3)c12
CHEMBL3608450,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,719.0,nM,CHEMBL3610522,B,Binding affinity to alpha2A adrenoceptor (unknown origin),CHEMBL3608284,KI,COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2c1ccccc1)OCO4
CHEMBL3735756,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,102.0,nM,CHEMBL3736691,B,Displacement of [3H]Rauwolscine from human recombinant alpha 2A receptor stably expressed in MDCK cells after 90 mins by scintillation counting method,CHEMBL3734659,KI,COc1ccc(CCN(CCCc2ccccc2)CCc2ccc3c(c2)OCO3)cc1OC
CHEMBL3754496,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,117.49,nM,CHEMBL3756288,B,Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay,CHEMBL3751848,KI,C=CCN(CC=C)CCc1c[nH]c2ccc(F)cc12
CHEMBL3752900,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,81.28,nM,CHEMBL3756288,B,Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay,CHEMBL3751848,KI,C=CCN(CC=C)CCc1c[nH]c2ccc(Cl)cc12
CHEMBL3754166,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,83.18,nM,CHEMBL3756288,B,Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay,CHEMBL3751848,KI,C=CCN(CC=C)CCc1c[nH]c2ccc(Br)cc12
CHEMBL3753318,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,194.98,nM,CHEMBL3756288,B,Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay,CHEMBL3751848,KI,C=CCN(CC=C)CCc1c[nH]c2ccc(C)cc12
CHEMBL2391541,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,213.8,nM,CHEMBL3756288,B,Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay,CHEMBL3751848,KI,C=CCN(CC=C)CCc1c[nH]c2ccc(OC)cc12
CHEMBL3752576,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,123.03,nM,CHEMBL3756288,B,Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay,CHEMBL3751848,KI,C=CCN(CC=C)CCc1c[nH]c2ccccc12
CHEMBL3769968,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,165.96,nM,CHEMBL3774020,B,Binding affinity to human alpha-2A adrenergic receptor by radioligand binding assay,CHEMBL3769385,KI,C=CCOc1cc(F)c(F)cc1C1CC1CN.Cl
CHEMBL3769968,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,661.0,nM,CHEMBL3774020,B,Binding affinity to human alpha-2A adrenergic receptor by radioligand binding assay,CHEMBL3769385,KI,C=CCOc1cc(F)c(F)cc1C1CC1CN.Cl
CHEMBL3897499,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1586.0,nM,CHEMBL3869815,B,Displacement of [3H]Rauwolscine from human Alpha2A receptor expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method,CHEMBL3868615,KI,CCCN1CC[C@H]2c3cc4ccc(C(F)(F)F)cc4nc3[C@H](CC)[C@H]3CCC[C@@H]1[C@@H]32
CHEMBL4082473,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2570.0,nM,CHEMBL4009062,B,Displacement of [3H] MK-912 from human adrenergic alpha 2A receptor expressed in HT29 cells after 60 mins,CHEMBL4007422,KI,COc1ccc2c(c1)c(CN1CCN(C)CC1)cn2S(=O)(=O)c1ccccc1Br.CS(=O)(=O)O.O
CHEMBL4090355,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,5000.0,nM,CHEMBL4011363,B,Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptor,CHEMBL4007505,KI,CNC(=O)[C@H]1O[C@@H](n2cnc3c(NC)nc(C#Cc4ccc(Cl)s4)nc32)[C@H](O)[C@@H]1O
CHEMBL4086593,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,5000.0,nM,CHEMBL4011363,B,Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptor,CHEMBL4007505,KI,CCCNc1nc(C#Cc2ccc(Cl)s2)nc2c1ncn2[C@@H]1O[C@H](C(=O)NC)[C@@H](O)[C@H]1O
CHEMBL267014,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,170.0,nM,CHEMBL4039173,B,Inhibition of alpha2A adrenergic receptor (unknown origin),CHEMBL4038300,KI,Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1
CHEMBL346389,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,411.0,nM,CHEMBL4039173,B,Inhibition of alpha2A adrenergic receptor (unknown origin),CHEMBL4038300,KI,O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1
CHEMBL146556,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,249.0,nM,CHEMBL4039173,B,Inhibition of alpha2A adrenergic receptor (unknown origin),CHEMBL4038300,KI,c1ccc2c(c1)CC(CN1CCN(c3ccc4c(c3)OCCO4)CC1)C2
CHEMBL4161503,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2089.0,nM,CHEMBL4153397,B,Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method,CHEMBL4152214,KI,c1ccc(CN2Cc3ccc(N4CCOCC4)cc3C2)cc1
CHEMBL4169752,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,321.0,nM,CHEMBL4153397,B,Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method,CHEMBL4152214,KI,c1ccc(CN2CCc3cc(N4CCOCC4)ccc3C2)cc1
CHEMBL4167315,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1685.0,nM,CHEMBL4153397,B,Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method,CHEMBL4152214,KI,COc1cccc(-c2ccc3c(c2)CN(Cc2ccccc2)C3)c1
CHEMBL4163428,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,487.0,nM,CHEMBL4153397,B,Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method,CHEMBL4152214,KI,CN1CCN(c2ccc3c(c2)CN(C(=O)OCc2ccccc2)C3)CC1
CHEMBL4173095,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,876.0,nM,CHEMBL4153397,B,Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method,CHEMBL4152214,KI,C=C(C)CN1CCN(c2ccc3c(c2)CN(C(=O)OCc2ccccc2)CC3)CC1
CHEMBL4165863,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,506.0,nM,CHEMBL4153397,B,Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method,CHEMBL4152214,KI,O=C(OCc1ccccc1)N1CCc2ccc(N3CCN(C4CCCC4)CC3)cc2C1
CHEMBL4217398,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,5280.0,nM,CHEMBL4189959,B,Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptor expressed in MDCK cell membranes after 90 mins by scintillation counting method,CHEMBL4184336,KI,CC(C)(C)OC(=O)NCCCCCCn1cc(CCCCN2CCC(c3ccc(-c4cc(C(=O)O)cc5cc(-c6ccc(C(F)(F)F)cc6)ccc45)cc3)CC2)nn1
CHEMBL4216870,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,28.0,nM,CHEMBL4189959,B,Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptor expressed in MDCK cell membranes after 90 mins by scintillation counting method,CHEMBL4184336,KI,NCCCCCCn1cc(CCCCN2CCC(c3ccc(-c4cc(C(=O)O)cc5cc(-c6ccc(C(F)(F)F)cc6)ccc45)cc3)CC2)nn1
CHEMBL4285281,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1147.0,nM,CHEMBL4258838,B,Binding affinity to andrenergic alpha2A receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assay,CHEMBL4257493,KI,COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2
CHEMBL76,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4365.16,nM,CHEMBL4303095,B,Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine,CHEMBL4303773,KI,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12
CHEMBL1626,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,169.82,nM,CHEMBL4303095,B,Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine,CHEMBL4303773,KI,CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1
CHEMBL1535,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,6456.54,nM,CHEMBL4303095,B,Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine,CHEMBL4303773,KI,CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12
CHEMBL53325,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1513.56,nM,CHEMBL4303095,B,Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine,CHEMBL4303773,KI,COc1cccc2c1CCCC2CCCN1CCN(C2CCCCC2)CC1
CHEMBL4088272,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,8317.64,nM,CHEMBL4303095,B,Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine,CHEMBL4303773,KI,CCCN1CCC=C(c2cc(-c3ccc(C)cc3)no2)C1
CHEMBL4472703,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,6309.57,nM,CHEMBL4308618,B,Displacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method,CHEMBL4304834,KI,CC[C@H]1c2cc(OC)ccc2CC[C@@]1(C)N
CHEMBL4572167,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,398.11,nM,CHEMBL4308618,B,Displacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method,CHEMBL4304834,KI,CC[C@H]1c2ccccc2N(c2ccccc2)C[C@@]1(C)N
CHEMBL4442460,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,400.0,nM,CHEMBL4323488,B,Displacement of [3H] RX821002 from alpha2A adrenergic receptor (unknown origin),CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccccc2)CC1
CHEMBL4544086,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,860.0,nM,CHEMBL4323488,B,Displacement of [3H] RX821002 from alpha2A adrenergic receptor (unknown origin),CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(F)cc2)c2ccccc2)CC1
CHEMBL4533687,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3715.35,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(Oc4ccccc4)cc3)C(=O)C21
CHEMBL4590209,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,7585.78,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(-c4ccccc4)cc3)C(=O)C21
CHEMBL4438801,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.06607,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3cccc([N+](=O)[O-])c3)C(=O)C21
CHEMBL4459403,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,6918.31,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3c(Cl)cc(Cl)cc3Cl)C(=O)C21
CHEMBL4456882,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,602.56,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3cc(Cl)cc(Cl)c3)C(=O)C21
CHEMBL4528557,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,707.95,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccccc3Cl)C(=O)C21
CHEMBL4475933,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4570.88,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(F)cc3)C(=O)C21
CHEMBL4476557,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,18620.87,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(C(F)(F)F)cc3)C(=O)C21
CHEMBL4553853,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,363078.05,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(C3Cc4ccccc4C3)C(=O)C21
CHEMBL4587003,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2238.72,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(CCc3ccc(F)cc3)C(=O)C21
CHEMBL4434967,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,169824.37,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(CCc3ccccc3)C(=O)C21
CHEMBL4438158,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,7.762,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(Cc3ccccc3)C(=O)C21
CHEMBL4445396,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,48977.88,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(CC34CC5CC(CC(C5)C3)C4)C(=O)C21
CHEMBL4554450,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,169.82,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(C(C)(C)C)C(=O)C21
CHEMBL4587519,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1412.54,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(CC)C(=O)C21
CHEMBL4568994,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,63.1,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(Cc2ccc(F)cc2)N=CC2C(=O)N(c3ccccc3)C(=O)C21
CHEMBL4469237,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,114815.36,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(Cc2ccccc2)N=CC2C(=O)N(c3ccccc3)C(=O)C21
CHEMBL4584406,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,141253.75,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccc(OC)cc2)N=CC2C(=O)N(c3ccccc3)C(=O)C21
CHEMBL4465834,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,416869.38,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccc(F)cc2)N=CC2C(=O)N(c3ccc(F)c(Cl)c3)C(=O)C21
CHEMBL4454147,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,169.82,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccc(F)cc2)N=CC2C(=O)N(c3ccccc3)C(=O)C21
CHEMBL4534152,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,25703.96,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(OC)cc3)C(=O)C21
CHEMBL4450506,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,537.03,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(F)c(Cl)c3)C(=O)C21
CHEMBL4450506,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,53.0,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(F)c(Cl)c3)C(=O)C21
CHEMBL4482861,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.04169,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccccc3)C(=O)C21
CHEMBL4535472,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.9772,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(C3CCCCC3)C(=O)C21
CHEMBL4459090,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1174.9,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(C)C(=O)C21
CHEMBL4536304,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.0537,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1N=CC2C(=O)N(c3ccc(OC)cc3)C(=O)C21
CHEMBL4439953,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3.236,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1N=CC2C(=O)N(c3ccc(F)c(Cl)c3)C(=O)C21
CHEMBL4546903,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,9549.93,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1N=CC2C(=O)N(c3ccccc3)C(=O)C21
CHEMBL4483022,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,0.3236,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1N=CC2C(=O)N(C3CCCCC3)C(=O)C21
CHEMBL4467833,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4.467,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,CCOP(=O)(OCC)C1N=CC2C(=O)N(C)C(=O)C21
CHEMBL151697,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,6760.83,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,c1ccc2oc(-c3ncc[nH]3)cc2c1
CHEMBL404505,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,229.09,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,c1ccc2oc(C3=NCCN3)cc2c1
CHEMBL275970,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,46773.51,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,C(=C/c1ccccc1)\C1=NCCN1
CHEMBL2179398,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2238721.14,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,c1ccc(-c2ncc3cc(-n4ccnc4)ccc3n2)cc1
CHEMBL41103,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,42657.95,nM,CHEMBL4358950,B,Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry,CHEMBL4354864,KI,Cn1c(C2=NCCN2)cc2ccccc21
CHEMBL4471712,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,6960.0,nM,CHEMBL4369998,B,Inhibition of alpha2a receptor (unknown origin),CHEMBL4368904,KI,O[C@@H]1[C@H](O)[C@@H]2C[C@@H]2[C@H]1n1cnc2c(NC(C3CCC3)C3CCC3)nc(Cl)nc21
CHEMBL4554295,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,6800.0,nM,CHEMBL4369998,B,Inhibition of alpha2a receptor (unknown origin),CHEMBL4368904,KI,O[C@H]1[C@H](n2cnc3c(NC(C4CCC4)C4CCC4)ncnc32)[C@H]2C[C@@]2(CCl)[C@H]1O
CHEMBL299031,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4720.0,nM,CHEMBL4380088,B,Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 mins,CHEMBL4376854,KI,CC[C@@H]1CN2CCc3c([nH]c4cccc(OC)c34)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC
CHEMBL15245,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3.13,nM,CHEMBL4380088,B,Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 mins,CHEMBL4376854,KI,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
CHEMBL4277264,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3400.0,nM,CHEMBL4392148,B,Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method,CHEMBL4390674,KI,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12
CHEMBL4572614,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,6800.0,nM,CHEMBL4392148,B,Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method,CHEMBL4390674,KI,Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1C(F)(F)F
CHEMBL4469848,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,5100.0,nM,CHEMBL4392148,B,Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method,CHEMBL4390674,KI,FC(F)(F)c1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12
CHEMBL4466483,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2600.0,nM,CHEMBL4392148,B,Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method,CHEMBL4390674,KI,FC(F)(F)c1cc(Oc2nccc3ccsc23)ccc1-c1cccc2nccn12
CHEMBL4514672,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3364.0,nM,CHEMBL4423338,B,Displacement of [3H] NECA from human adrenergic alpha 2A receptor expressed in MDCK cells by radioligand binding assay,CHEMBL4422623,KI,CC1=NC2(CCN(C)CC2)C(=O)N(c2c(C)cccc2C)C1=O
CHEMBL4544251,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1560.0,nM,CHEMBL4426521,B,Binding affinity to human alpha2A receptor expressed in MDCK cells by PDSP assay,CHEMBL4425123,KI,O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)cc(-n2cc(-c3ccc(Cl)s3)nn2)c1
CHEMBL4633982,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,960.0,nM,CHEMBL4622305,B,Binding affinity to adrenergic alpha2A receptor (unknown origin),CHEMBL4619807,KI,O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)cc(-c2cn(-c3ccc(C(F)(F)F)cc3)nn2)c1
CHEMBL49623,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1600.0,nM,CHEMBL4713191,B,Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin),CHEMBL4706656,KI,C[C@@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1
CHEMBL113830,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2300.0,nM,CHEMBL4713191,B,Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin),CHEMBL4706656,KI,C[C@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1
CHEMBL493054,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,5500.0,nM,CHEMBL4713191,B,Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin),CHEMBL4706656,KI,C[C@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1
CHEMBL319706,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,6100.0,nM,CHEMBL4713191,B,Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin),CHEMBL4706656,KI,C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1
CHEMBL4777306,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,531.0,nM,CHEMBL4723540,B,Binding affinity to alpha 2A adrenoceptor (unknown origin),CHEMBL4715859,KI,C=C1CCN2Cc3ccc(OC)cc3[C@H]3CCCC[C@]32C1
CHEMBL4784373,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,16.3,nM,CHEMBL4729782,B,Binding affinity to alpha2 adrenergic receptor (unknown origin),CHEMBL4725387,KI,CC(=O)Nc1ccc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1
CHEMBL85,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,28.2,nM,CHEMBL4729782,B,Binding affinity to alpha2 adrenergic receptor (unknown origin),CHEMBL4725387,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL4794963,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,193.0,nM,CHEMBL4729782,B,Binding affinity to alpha2 adrenergic receptor (unknown origin),CHEMBL4725387,KI,CC(=O)Nc1ccc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1
CHEMBL4848380,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3970.0,nM,CHEMBL4808697,B,Binding affinity to alpha2a (unknown origin),CHEMBL4808172,KI,O=CN1CCC(c2ccc(-c3cc(C(=O)O)cc4cc(-c5ccc(C(F)(F)F)cc5)ccc34)cc2)CC1
CHEMBL4875858,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4800.0,nM,CHEMBL4818332,B,Inhibition of alpha2a adrenergic receptor (unknown origin),CHEMBL4814049,KI,O=[N+]([O-])C1=Cc2cc(I)ccc2OC1C(F)(F)F
CHEMBL4851349,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4700.0,nM,CHEMBL4818332,B,Inhibition of alpha2a adrenergic receptor (unknown origin),CHEMBL4814049,KI,C[Si](C)(C)C#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2
CHEMBL4848838,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2200.0,nM,CHEMBL4818332,B,Inhibition of alpha2a adrenergic receptor (unknown origin),CHEMBL4814049,KI,CC(=O)NCC#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2
CHEMBL4856060,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,940.0,nM,CHEMBL4818332,B,Inhibition of alpha2a adrenergic receptor (unknown origin),CHEMBL4814049,KI,CC(C)(C)OC(=O)NCC#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2
CHEMBL4857492,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1800.0,nM,CHEMBL4818332,B,Inhibition of alpha2a adrenergic receptor (unknown origin),CHEMBL4814049,KI,O=C(O)c1ccc(C#Cc2ccc3c(c2)C=C([N+](=O)[O-])C(C(F)(F)F)O3)cc1
CHEMBL4845850,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,650.0,nM,CHEMBL4818332,B,Inhibition of alpha2a adrenergic receptor (unknown origin),CHEMBL4814049,KI,O=C1c2ccccc2C(=O)N1CC#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2
CHEMBL4867565,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,110.0,nM,CHEMBL4844539,B,Binding affinity to human adrenergic alpha 2A receptor,CHEMBL4842371,KI,O=S(=O)(c1cccc(F)c1)n1ccc2c(N3CCNCC3)nc3ccccc3c21
CHEMBL4535474,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,381.33,nM,CHEMBL4880052,B,GPCRScan assay: inhibition of Alpha2A,CHEMBL4507273,KI,CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
CHEMBL4535474,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,380.19,nM,CHEMBL4880052,B,GPCRScan assay: inhibition of Alpha2A,CHEMBL4507273,KI,CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
CHEMBL4520788,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,127.42,nM,CHEMBL4880052,B,GPCRScan assay: inhibition of Alpha2A,CHEMBL4507273,KI,CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
CHEMBL4520788,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,125.89,nM,CHEMBL4880052,B,GPCRScan assay: inhibition of Alpha2A,CHEMBL4507273,KI,CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
CHEMBL4558518,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,237.0,nM,CHEMBL4880052,B,GPCRScan assay: inhibition of Alpha2A,CHEMBL4507288,KI,CC(C)(C)OC(=O)N1CCCC1CNC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1
CHEMBL4558518,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,234.42,nM,CHEMBL4880052,B,GPCRScan assay: inhibition of Alpha2A,CHEMBL4507288,KI,CC(C)(C)OC(=O)N1CCCC1CNC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1
CHEMBL1800685,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1530.0,nM,CHEMBL4880897,B,Adrenergic alpha2A Eurofins-Panlabs radioligand binding assay,CHEMBL4507292,KI,O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1
CHEMBL3582478,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2606.75,nM,CHEMBL4880052,B,GPCRScan assay: inhibition of Alpha2A,CHEMBL4507294,KI,CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1
CHEMBL3582478,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2630.27,nM,CHEMBL4880052,B,GPCRScan assay: inhibition of Alpha2A,CHEMBL4507294,KI,CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1
CHEMBL3480577,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,10000.0,nM,CHEMBL4880052,B,GPCRScan assay: inhibition of Alpha2A,CHEMBL4507309,KI,Cc1ccc2nc(CNCCCOc3ccccc3)cc(O)c2c1
CHEMBL3480577,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1000000000.0,nM,CHEMBL4880052,B,GPCRScan assay: inhibition of Alpha2A,CHEMBL4507309,KI,Cc1ccc2nc(CNCCCOc3ccccc3)cc(O)c2c1
CHEMBL4549667,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2355.74,nM,CHEMBL4880052,B,GPCRScan assay: inhibition of Alpha2A,CHEMBL4507326,KI,CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21
CHEMBL4549667,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2344.23,nM,CHEMBL4880052,B,GPCRScan assay: inhibition of Alpha2A,CHEMBL4507326,KI,CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21
CHEMBL5191141,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,560.0,nM,CHEMBL5117900,B,Displacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysis,CHEMBL5113485,KI,[2H]c1c([2H])c([2H])c([C@@H]2C[C@@H](N3CCN(C([2H])([2H])[2H])C(C)(C)C3)c3cc(Cl)ccc32)c([2H])c1[2H]
CHEMBL5201983,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2500.0,nM,CHEMBL5117900,B,Displacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysis,CHEMBL5113485,KI,[2H]c1c([2H])c([2H])c([C@@H]2C[C@@H](N3CCNC(C)(C)C3)c3cc(Cl)ccc32)c([2H])c1[2H]
CHEMBL4520788,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,127.42,nM,CHEMBL5213951,B,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000743a ADRA2A,CHEMBL5212743,KI,CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
CHEMBL4558518,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,237.0,nM,CHEMBL5213923,B,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000741a ADRA2A,CHEMBL5212743,KI,CC(C)(C)OC(=O)N1CCCC1CNC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1
CHEMBL4549667,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2355.74,nM,CHEMBL5213520,B,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000720a ADRA2A,CHEMBL5212743,KI,CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21
CHEMBL4576555,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2659.0,nM,CHEMBL5213377,B,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000705a ADRA2A,CHEMBL5212743,KI,CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1
CHEMBL4576555,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2658.89,nM,CHEMBL4880052,B,GPCRScan assay: inhibition of Alpha2A,CHEMBL4507307,KI,CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1
CHEMBL4576555,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2630.27,nM,CHEMBL4880052,B,GPCRScan assay: inhibition of Alpha2A,CHEMBL4507307,KI,CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1
CHEMBL4642079,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,8468.01,nM,CHEMBL4880052,B,GPCRScan assay: inhibition of Alpha2A,CHEMBL4630901,KI,Cc1c(N2CCNCC2)nc2ccc(Br)cc2c1C(=O)NC[C@H](CCC(=O)O)c1ccccc1Cl
CHEMBL4642079,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,8511.38,nM,CHEMBL4880052,B,GPCRScan assay: inhibition of Alpha2A,CHEMBL4630901,KI,Cc1c(N2CCNCC2)nc2ccc(Br)cc2c1C(=O)NC[C@H](CCC(=O)O)c1ccccc1Cl
CHEMBL5094181,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3826.48,nM,CHEMBL4880052,B,GPCRScan assay: inhibition of Alpha2A,CHEMBL5058647,KI,O=C(NCCCn1ccnc1)c1cc2nc(-c3ccccc3)cc(-c3ccccc3)n2n1
CHEMBL5094181,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3801.89,nM,CHEMBL4880052,B,GPCRScan assay: inhibition of Alpha2A,CHEMBL5058647,KI,O=C(NCCCn1ccnc1)c1cc2nc(-c3ccccc3)cc(-c3ccccc3)n2n1
CHEMBL5395401,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2738.0,nM,CHEMBL5319340,B,Binding affinity to alpha2A receptor (unknown origin) assessed as inhibition constant,CHEMBL5316327,KI,CCN(CC)CCCC(C)Nc1cnc(C(=O)Nc2ccc(Cl)c3cccnc23)cn1
CHEMBL5431371,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,673.0,nM,CHEMBL5319340,B,Binding affinity to alpha2A receptor (unknown origin) assessed as inhibition constant,CHEMBL5316327,KI,CCN(CC)CCCC(C)Nc1cnc(C(=O)Nc2cc(F)cc3cccnc23)cn1
CHEMBL5400876,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,356.0,nM,CHEMBL5325023,B,Binding affinity to alpha2A adrenergic receptor (unknown origin) assessed as inhibition constant,CHEMBL5321291,KI,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1
CHEMBL5404195,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,5700.0,nM,CHEMBL5334885,B,Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor assessed as inhibition constant by radioligand displacement assay,CHEMBL5331128,KI,O=C(O)c1cc(-c2ccc(C3(O)C[C@H]4CNC[C@@H]4C3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1
CHEMBL5403404,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1031.0,nM,CHEMBL5339608,B,Binding affinity to human alpha 2A adrenergic receptor assessed as inhibition constant,CHEMBL5338720,KI,CCCN1CCN(c2ccc3c(c2)C(N(C)C(=O)OCc2ccccc2)CCC3)CC1
CHEMBL5400232,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,28.0,nM,CHEMBL5351455,B,Displacement of [3H]RX821002 from adrenergic alpha 2A receptor (unknown origin) expressed in HEK293T cells assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL5422870,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,410.0,nM,CHEMBL5351455,B,Displacement of [3H]RX821002 from adrenergic alpha 2A receptor (unknown origin) expressed in HEK293T cells assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COCCOCCOc1ccc(NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c(-c2ccccc2)c1
CHEMBL5394229,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,150.0,nM,CHEMBL5351455,B,Displacement of [3H]RX821002 from adrenergic alpha 2A receptor (unknown origin) expressed in HEK293T cells assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2ccc(-c3ccccc3)cc2)CC1
CHEMBL5425252,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,120.0,nM,CHEMBL5351455,B,Displacement of [3H]RX821002 from adrenergic alpha 2A receptor (unknown origin) expressed in HEK293T cells assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2ccccc2)CC1
CHEMBL5403204,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,200.0,nM,CHEMBL5351455,B,Displacement of [3H]RX821002 from adrenergic alpha 2A receptor (unknown origin) expressed in HEK293T cells assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccc(-c2ccccc2)c(CNC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL5398630,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1520.0,nM,CHEMBL5372901,B,Displacement of [3H]-rauwolscine from human recombinant adrenergic alpha-2A receptor expressed in CHO-K1 cells assessed as inhibition constant incubated for 60 mins by spectrophotometric analysis,CHEMBL5370593,KI,O=C(O)/C=C/C(=O)O.[2H]C([2H])(Cc1c[nH]c2ccccc12)N(C)C
CHEMBL3183055,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1110.0,nM,CHEMBL5372901,B,Displacement of [3H]-rauwolscine from human recombinant adrenergic alpha-2A receptor expressed in CHO-K1 cells assessed as inhibition constant incubated for 60 mins by spectrophotometric analysis,CHEMBL5370593,KI,CN(C)CCc1c[nH]c2ccccc12.O=C(O)/C=C/C(=O)O
CHEMBL5398701,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,8000.0,nM,CHEMBL5393365,B,Binding affinity to alpha2A adrenergic receptor (unknown origin),CHEMBL5390318,KI,CC(C)(C)Cc1c(C#Cc2ccc(F)c(F)c2)sc(N)c1C(=O)c1ccc(Cl)cc1
CHEMBL1256876,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,898.46,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cl.NC[C@@H]1O[C@H](C23CC4CC(CC(C4)C2)C3)Cc2c1ccc(O)c2O
CHEMBL1490875,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,4035.52,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Br.Br.N=C(N)SCCc1c[nH]cn1
CHEMBL1489369,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2852.66,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Br.CN1CCc2cc(Br)c(O)cc2C(c2ccccc2)C1
CHEMBL83894,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2018.37,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,O=S1(=O)c2cccc3cccc(c23)N1CCCN1CCN(c2ccc(F)cc2)CC1
CHEMBL405355,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2271.43,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1cccc([N+](=O)[O-])c1
CHEMBL24778,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,682.73,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F
CHEMBL1215,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3216.62,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CNC[C@H](O)c1cccc(O)c1
CHEMBL300555,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,616.88,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,O=C1NCN(c2ccccc2)C12CCN(CC1COc3ccccc3O1)CC2
CHEMBL445102,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,3847.25,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL1256998,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1525.11,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CCCCN1CCC(COC(=O)c2cc(Cl)c(N)c3c2OCCO3)CC1.Cl
CHEMBL2106195,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,50.55,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cc1cccc([C@H](C)c2c[nH]cn2)c1C.Cl
CHEMBL281350,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2431.08,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cc1nc(-c2ccc(-c3ccc(C(=O)N4CCc5cc6c(cc54)C4(CCN(C)CC4)CO6)cc3)c(C)c2)no1
CHEMBL103769,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,177.83,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,S=C(NCCCc1c[nH]cn1)NCCCN(Cc1ccc(Cl)c(Cl)c1)c1ccc(Br)cn1
CHEMBL59898,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,767.0,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CCOC(=O)c1c(C)[nH]c2ccc3c(c12)CN1CCc2cc(OC)ccc2C1O3
CHEMBL542139,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,589.99,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCNCC1.Cl
CHEMBL267777,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,367.45,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL1256844,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1178.29,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(O)c2)CC1.Cl
CHEMBL543113,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,242.27,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CN1C2CCC1CC(OC(c1ccc(F)cc1)c1ccc(F)cc1)C2.Cl
CHEMBL79834,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2284.29,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,O=C1NCN(c2ccccc2)C12CCN(CCCOc1ccc(F)cc1)CC2
CHEMBL1615374,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2494.41,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cl.N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1
CHEMBL214957,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2943.41,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,COc1cc(-n2cnc3cc(-c4ccc(Cl)cc4)sc3c2=O)ccc1OCCN1CCCC1
CHEMBL589390,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,728.95,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1
CHEMBL1200809,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1451.11,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1.Cl
CHEMBL1766103,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,852.22,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cc1cc(C)cc(-c2cnc3cc(Cl)c(-c4cccc(O)c4)cc3c2OCCCN)c1
CHEMBL1633,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1084.43,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1.O=C(O)/C=C/C(=O)O
CHEMBL1200492,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1370.88,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1.Cl
CHEMBL2024517,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1742.21,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1.Cl
CHEMBL1474387,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,568.33,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cc1c(P(=S)(c2ccccc2)c2ccccc2)n2ccccc2[n+]1C/C=C/c1ccccc1.[Br-]
CHEMBL2164327,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,647.22,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cc1nn(C)c(C)c1-c1cccc2c1CC[C@H](N(C)C)C2
CHEMBL2105760,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,212.25,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1
CHEMBL1200389,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,197.28,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Brc1c(NC2=NCCN2)ccc2nccnc12.O=C(O)[C@H](O)[C@@H](O)C(=O)O
CHEMBL1200517,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,14.62,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21.CS(=O)(=O)O
CHEMBL1257131,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,18.88,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,COC(=O)[C@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@H]2CC[C@@H]1O.Cl
CHEMBL5087452,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,5713.47,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,NC[C@H](O)c1ccc(O)c(O)c1.O.O=C(O)[C@H](O)[C@@H](O)C(=O)O
CHEMBL1705,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,163.03,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cl.Clc1cccc(Cl)c1NC1=NCCN1
CHEMBL1256863,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2157.0,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,NCCc1c[nH]c2ccc(C(N)=O)cc12.O=C(O)/C=C\C(=O)O
CHEMBL5076314,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,2272.48,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CN1CCN(c2ccc(Nc3c4ccccc4nc4ccccc34)cc2)CC1.Cl.Cl.O
CHEMBL540612,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,253.34,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1.Cl
CHEMBL567303,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,1018.35,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cc1cc(NC(=O)NCCN2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1
CHEMBL5075931,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,153.21,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,NCCc1cn(S(=O)(=O)c2c(Cl)nc3sccn23)c2ccccc12.O=C(O)C(=O)O
CHEMBL5089005,CHEMBL1867,Alpha-2a adrenergic receptor,Ki,=,440.05,nM,CHEMBL5442194,B,"PDSP Secondary Binding target: ADRA2A - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,COc1ccc(NC(=O)c2ccc(-c3ccc(-c4noc(C)n4)cc3C)cc2)cc1OCCN(C)C.Cl
CHEMBL15245,CHEMBL1867,Alpha-2a adrenergic receptor,EC50,=,8.5,nM,CHEMBL972062,B,Displacement of [3H]MK912 from human recombinant adrenergic alpha2A receptor expressed in Sf9 cells,CHEMBL1157299,EC50,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
CHEMBL4860528,CHEMBL1867,Alpha-2a adrenergic receptor,EC50,=,891.25,nM,CHEMBL5151494,B,Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis,CHEMBL5149991,EC50,CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C
CHEMBL5207281,CHEMBL1867,Alpha-2a adrenergic receptor,EC50,=,4897.79,nM,CHEMBL5151494,B,Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis,CHEMBL5149991,EC50,CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5206565,CHEMBL1867,Alpha-2a adrenergic receptor,EC50,=,1258.93,nM,CHEMBL5151494,B,Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis,CHEMBL5149991,EC50,N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5201074,CHEMBL1867,Alpha-2a adrenergic receptor,EC50,=,851.14,nM,CHEMBL5151494,B,Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis,CHEMBL5149991,EC50,C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1.Cl.Cl
CHEMBL3335523,CHEMBL1867,Alpha-2a adrenergic receptor,Kd,=,1.03,nM,CHEMBL3390263,B,"Displacement of [3H]4-[2-[7-amino-2-(2-furyl)-1,2,4-triazolo[1,5-a][1,3,5]triazin-5-yl-amino]ethylphenol from human adenosine A2a receptor K150A mutant expressed in COS-7 cells assessed as radioligand Kd compound preincubated for 30 mins",CHEMBL3352600,KD,CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(CCC(=O)Nc5ccc(OC(C)=O)c([N+](=O)[O-])c5)cc4)nc32)[C@H](O)[C@@H]1O
CHEMBL4860528,CHEMBL1867,Alpha-2a adrenergic receptor,Kd,=,0.6,nM,CHEMBL5151494,B,Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis,CHEMBL5149991,KD,CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C
CHEMBL5207281,CHEMBL1867,Alpha-2a adrenergic receptor,Kd,=,0.6,nM,CHEMBL5151494,B,Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis,CHEMBL5149991,KD,CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5206565,CHEMBL1867,Alpha-2a adrenergic receptor,Kd,=,0.6,nM,CHEMBL5151494,B,Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis,CHEMBL5149991,KD,N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5201074,CHEMBL1867,Alpha-2a adrenergic receptor,Kd,=,0.6,nM,CHEMBL5151494,B,Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis,CHEMBL5149991,KD,C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1.Cl.Cl
CHEMBL4297337,CHEMBL1867,Alpha-2a adrenergic receptor,Kd,=,109.0,nM,CHEMBL5341751,B,Binding affinity to alpha2A receptor (unknown origin),CHEMBL5338767,KD,[11CH3]OCc1cccnc1N1CCN(C[C@H]2COc3ccccc3O2)CC1
